<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1455" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1455/" /><meta name="ncbi_pagename" content="FGFR-Related Craniosynostosis Syndromes - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>FGFR-Related Craniosynostosis Syndromes - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="FGFR-Related Craniosynostosis Syndromes" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2011/06/07" /><meta name="citation_author" content="Nathaniel H Robin" /><meta name="citation_author" content="Marni J Falk" /><meta name="citation_author" content="Chad R Haldeman-Englert" /><meta name="citation_pmid" content="20301628" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1455/" /><meta name="citation_keywords" content="Acrocephalosyndactyly" /><meta name="citation_keywords" content="FGFR2-Related Craniosynostosis" /><meta name="citation_keywords" content="FGFR1-Related Craniosynostosis" /><meta name="citation_keywords" content="FGFR3-Related Craniosynostosis" /><meta name="citation_keywords" content="Fibroblast growth factor receptor 1" /><meta name="citation_keywords" content="Fibroblast growth factor receptor 2" /><meta name="citation_keywords" content="Fibroblast growth factor receptor 3" /><meta name="citation_keywords" content="FGFR1" /><meta name="citation_keywords" content="FGFR2" /><meta name="citation_keywords" content="FGFR3" /><meta name="citation_keywords" content="FGFR-Related Craniosynostosis" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="FGFR-Related Craniosynostosis Syndromes" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Nathaniel H Robin" /><meta name="DC.Contributor" content="Marni J Falk" /><meta name="DC.Contributor" content="Chad R Haldeman-Englert" /><meta name="DC.Date" content="2011/06/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1455/" /><meta name="description" content="The eight disorders comprising the FGFR-related craniosynostosis spectrum are Pfeiffer syndrome, Apert syndrome, Crouzon syndrome, Beare-Stevenson syndrome, FGFR2-related isolated coronal synostosis, Jackson-Weiss syndrome, Crouzon syndrome with acanthosis nigricans (AN), and Muenke syndrome (isolated coronal synostosis caused by the p.Pro250Arg pathogenic variant in FGFR3). Muenke syndrome and FGFR2-related isolated coronal synostosis are characterized only by uni- or bicoronal craniosynostosis; the remainder are characterized by bicoronal craniosynostosis or cloverleaf skull, distinctive facial features, and variable hand and foot findings." /><meta name="og:title" content="FGFR-Related Craniosynostosis Syndromes" /><meta name="og:type" content="book" /><meta name="og:description" content="The eight disorders comprising the FGFR-related craniosynostosis spectrum are Pfeiffer syndrome, Apert syndrome, Crouzon syndrome, Beare-Stevenson syndrome, FGFR2-related isolated coronal synostosis, Jackson-Weiss syndrome, Crouzon syndrome with acanthosis nigricans (AN), and Muenke syndrome (isolated coronal synostosis caused by the p.Pro250Arg pathogenic variant in FGFR3). Muenke syndrome and FGFR2-related isolated coronal synostosis are characterized only by uni- or bicoronal craniosynostosis; the remainder are characterized by bicoronal craniosynostosis or cloverleaf skull, distinctive facial features, and variable hand and foot findings." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1455/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/craniosynostosis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1455/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CDD20E0410B3100000000013A0078.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1455_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1455_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fbxl4-mtddepl/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fkbp14-keds/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1455_"><span class="title" itemprop="name"><i>FGFR</i>-Related Craniosynostosis Syndromes</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Acrocephalosyndactyly</div><p class="contrib-group"><span itemprop="author">Nathaniel H Robin</span>, MD, <span itemprop="author">Marni J Falk</span>, MD, and <span itemprop="author">Chad R Haldeman-Englert</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1455_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1455_ai__"><div class="contrib half_rhythm"><span itemprop="author">Nathaniel H Robin</span>, MD<div class="affiliation small">Departments of Genetics and Pediatrics<br />University of Alabama at Birmingham<br />Birmingham, Alabama<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.bau@niborn" class="oemail">ude.bau@niborn</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Marni J Falk</span>, MD<div class="affiliation small">Division of Human Genetics<br />Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@mklaf" class="oemail">ude.pohc.liame@mklaf</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Chad R Haldeman-Englert</span>, MD<div class="affiliation small">Fullerton Genetics Center<br />Asheville, North Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.jsm@trelgne-namedlah.dahc" class="oemail">gro.jsm@trelgne-namedlah.dahc</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 20, 1998</span>; Last Update: <span itemprop="dateModified">June 7, 2011</span>.</p><p><em>Estimated reading time: 42 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="craniosynostosis.Summary" itemprop="description"><h2 id="_craniosynostosis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The eight disorders comprising the <i>FGFR</i>-related craniosynostosis spectrum are Pfeiffer syndrome, Apert syndrome, Crouzon syndrome, Beare-Stevenson syndrome, <i>FGFR2</i>-related <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> coronal synostosis, Jackson-Weiss syndrome, Crouzon syndrome with acanthosis nigricans (AN), and Muenke syndrome (isolated coronal synostosis caused by the p.Pro250Arg <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR3</i>). Muenke syndrome and <i>FGFR2</i>-related isolated coronal synostosis are characterized only by uni- or bicoronal craniosynostosis; the remainder are characterized by bicoronal craniosynostosis or cloverleaf skull, distinctive facial features, and variable hand and foot findings.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Muenke syndrome is based on identification of the p.Pro250Arg <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR3</i>; the diagnosis of <i>FGFR2</i>-related <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> coronal synostosis is based on identification of a <i>FGFR2</i> pathogenic variant. The diagnosis of the other six <i>FGFR</i>-related craniosynostosis syndromes is based on clinical findings; <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>FGFR1</i>, <i>FGFR2</i>, and <i>FGFR3</i> may be helpful in establishing the specific diagnosis in questionable cases.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Management by a multidisciplinary craniofacial clinic affiliated with a major pediatric medical center when possible; <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> craniosynostosis usually requires a series of staged surgical procedures (craniotomy and fronto-orbital advancement) tailored to individual needs; for syndromic craniosynostosis, the first surgery is often as early as age three months, for nonsyndromic craniosynostosis the first surgery is often between ages six months and one year; <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> spine anomalies need immediate attention; surgical correction of limb defects depends on the nature of the skeletal anomalies.</p><p><i>Prevention of secondary complications</i>: Early treatment of craniofacial anomalies may reduce the risk for secondary complications such as hydrocephalus and cognitive impairment; ophthalmologic lubrication can prevent exposure keratopathy in those with severe proptosis.</p><p><i>Surveillance</i>: For hydrocephalus in those at increased risk.</p><p><i>Evaluation of relatives at risk</i>: Clinical and radiographic evaluation, or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known, so that mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relatives can benefit from early intervention.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>The <i>FGFR</i>-related craniosynostosis syndromes are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Affected individuals have a 50% chance of passing the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to each child. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant has been identified in the family; however, its use is limited by poor predictive value.</p></div></div><div id="craniosynostosis.GeneReview_Scope"><h2 id="_craniosynostosis_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="craniosynostosis.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1455/table/craniosynostosis.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__craniosynostosis.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_craniosynostosis.Tc_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR</i>-Related Craniosynostosis Syndromes: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_craniosynostosis.Tc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR1</i>-related craniosynostosis</td><td headers="hd_h_craniosynostosis.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Pfieffer syndrome type 1</div></li><li class="half_rhythm"><div>Pfeiffer syndrome type 2</div></li><li class="half_rhythm"><div>Pfeiffer syndrome type 3</div></li></ul></td></tr><tr><td headers="hd_h_craniosynostosis.Tc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR2</i>-related craniosynostosis</td><td headers="hd_h_craniosynostosis.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div><a href="/books/n/gene/apert/">Apert syndrome</a></div></li><li class="half_rhythm"><div>Beare-Stevenson syndrome</div></li><li class="half_rhythm"><div>Crouzon syndrome</div></li><li class="half_rhythm"><div>Isolated coronal synostosis</div></li><li class="half_rhythm"><div>Jackson-Weiss syndrome</div></li><li class="half_rhythm"><div>Pfeiffer syndrome type 1</div></li><li class="half_rhythm"><div>Pfeiffer syndrome type 2</div></li><li class="half_rhythm"><div>Pfeiffer syndrome type 3</div></li></ul></td></tr><tr><td headers="hd_h_craniosynostosis.Tc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR3</i>-related craniosynostosis</td><td headers="hd_h_craniosynostosis.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Crouzon syndrome with acanthosis nigricans</div></li><li class="half_rhythm"><div>Isolated coronal synostosis (including <a href="/books/n/gene/muenke/">Muenke syndrome</a>)</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#craniosynostosis.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="craniosynostosis.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes, see <a href="#craniosynostosis.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="craniosynostosis.Diagnosis"><h2 id="_craniosynostosis_Diagnosis_">Diagnosis</h2><div id="craniosynostosis.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>The phenotypes associated with <i>FGFR</i>-related craniosynostosis were clinically defined long before the molecular basis of this group of disorders was discovered (see <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.distinguishing_clinic/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTdistinguishingclinic" rid-ob="figobcraniosynostosisTdistinguishingclinic">Table 1</a>).</p><p>Six of the eight <i>FGFR</i>-related craniosynostosis disorders can be diagnosed primarily on the clinical findings of:</p><ul><li class="half_rhythm"><div>Unicoronal or bicoronal craniosynostosis (rather than sagittal or metopic craniosynostosis) or cloverleaf skull, usually based on clinical findings that can be confirmed by skull radiograph or head CT examination;</div></li><li class="half_rhythm"><div>Characteristic facial features;</div></li><li class="half_rhythm"><div>Variable hand and foot findings.</div></li></ul><p>Two of the eight <i>FGFR</i>-related craniosynostosis disorders require <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>:</p><ul><li class="half_rhythm"><div>Muenke syndrome may have unilateral coronal synostosis or megalencephaly without craniosynostosis; diagnosis is based on identification of the <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr3_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr3pathog" rid-ob="figobcraniosynostosisTselectedfgfr3pathog">p.Pro250Arg</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR3.</i></div></li><li class="half_rhythm"><div><i>FGFR2</i>-related <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> coronal synostosis is characterized by uni- or bicoronal craniosynostosis only; diagnosis is based on identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR2</i>.</div></li></ul><div id="craniosynostosis.T.distinguishing_clinic" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Distinguishing Clinical Features in the <i>FGFR</i>-Related Craniosynostosis Syndromes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1455/table/craniosynostosis.T.distinguishing_clinic/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__craniosynostosis.T.distinguishing_clinic_lrgtbl__"><table><thead><tr><th id="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Thumbs</th><th id="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hands</th><th id="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Great Toes</th><th id="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Feet</th></tr></thead><tbody><tr><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Crouzon syndrome</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td></tr><tr><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Crouzon syndrome with acanthosis nigricans</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td></tr><tr><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/apert/">Apert syndrome</a></td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Occasionally fused to fingers</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Soft tissue &#x000b1; bone syndactyly</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Occasionally fused to toes</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Soft tissue &#x000b1; bone syndactyly</td></tr><tr><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pfeiffer syndrome</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Broad, medially deviated</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variable brachydactyly</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Broad, medially deviated</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variable brachydactyly</td></tr><tr><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/muenke/">Muenke syndrome</a></td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x000b1; Carpal fusion</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x000b1; Broad</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x000b1; Tarsal fusion</td></tr><tr><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Jackson-Weiss syndrome</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variable</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Broad, medially deviated</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Abnormal tarsals</td></tr><tr><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Beare-Stevenson syndrome</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td></tr><tr><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR2</i>-related <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> coronal synostosis</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_craniosynostosis.T.distinguishing_clinic_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td></tr></tbody></table></div></div></div><div id="craniosynostosis.Molecular_Genetic_Testi"><h3>Molecular Genetic Testing</h3><p><b>Genes.</b> Pathogenic variants in <i>FGFR1</i>, <i>FGFR2</i>, and <i>FGFR3</i> cause <i>FGFR</i>-related craniosynostosis (<a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.molecular_basis_of_fg/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTmolecularbasisoffg" rid-ob="figobcraniosynostosisTmolecularbasisoffg">Table 2</a>).</p><div id="craniosynostosis.T.molecular_basis_of_fg" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Molecular Basis of <i>FGFR</i>-Related Craniosynostosis Syndromes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1455/table/craniosynostosis.T.molecular_basis_of_fg/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__craniosynostosis.T.molecular_basis_of_fg_lrgtbl__"><table><thead><tr><th id="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of <i>FGFR</i>-Related Craniosynostosis Phenotypes Attributed to Mutation of This Gene</th></tr><tr><th headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2" id="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR1</i></th><th headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2" id="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR2</i></th><th headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2" id="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR3</i></th></tr></thead><tbody><tr><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Crouzon syndrome</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Crouzon syndrome with acanthosis nigricans</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/apert/">Apert syndrome</a></td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pfeiffer syndrome type 1</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">95%</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pfeiffer syndrome type 2</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pfeiffer syndrome type 3</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/muenke/">Muenke syndrome</a></td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Jackson-Weiss syndrome</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Beare-Stevenson syndrome</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;100%</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR2</i>-related <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> coronal synostosis</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_1_2 hd_h_craniosynostosis.T.molecular_basis_of_fg_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div><div id="craniosynostosis.T.molecular_genetic_tes" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>FGFR</i>-Related Craniosynostosis Syndromes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1455/table/craniosynostosis.T.molecular_genetic_tes/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__craniosynostosis.T.molecular_genetic_tes_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR1</i></td><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants</td><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr1_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr1pathog" rid-ob="figobcraniosynostosisTselectedfgfr1pathog">p.Pro252Arg&#x000a0;</a><sup>4</sup></td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR2</i></td><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup> (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of select exons&#x000a0;<sup>5</sup> and <a class="def" href="/books/n/gene/glossary/def-item/targeted-analysis-for-pathogenic-variants/">targeted analysis for pathogenic variants</a>&#x000a0;<sup>6</sup>)</td><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>7</sup></td><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR3</i></td><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants; see footnote 9</td></tr><tr><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants</td><td headers="hd_h_craniosynostosis.T.molecular_genetic_tes_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr3_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr3pathog" rid-ob="figobcraniosynostosisTselectedfgfr3pathog">p.Pro250Arg</a>&#x000a0;<sup>10</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="craniosynostosis.TF.3.1"><p class="no_margin">See <a href="/books/NBK1455/#craniosynostosis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="craniosynostosis.TF.3.2"><p class="no_margin">See <a href="#craniosynostosis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="craniosynostosis.TF.3.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected.. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="craniosynostosis.TF.3.4"><p class="no_margin">The <i>FGFR1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Pro252Arg is associated with Pfeiffer syndrome type 1.</p></div></dd><dt>5. </dt><dd><div id="craniosynostosis.TF.3.5"><p class="no_margin">Select exons most often include exons 8 and 10 and also 3, 5, 7, 9, 11, 14-17.</p></div></dd><dt>6. </dt><dd><div id="craniosynostosis.TF.3.6"><p class="no_margin">p.Pro253Arg, p.Ser252Trp, p.Ser252Leu, p.Gln289Pro, and p.Ala344Gly (see <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">Table 5</a>)</p></div></dd><dt>7. </dt><dd><div id="craniosynostosis.TF.3.7"><p class="no_margin">Testing that identifies deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>8. </dt><dd><div id="craniosynostosis.TF.3.8"><p class="no_margin">For example, the <i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in Apert syndrome described by <a class="bk_pop" href="#craniosynostosis.REF.bochukova.2009.204">Bochukova et al [2009]</a></p></div></dd><dt>9. </dt><dd><div id="craniosynostosis.TF.3.9"><p class="no_margin">The causative <i>FGFR3</i> variant in Crouzon syndrome with AN is usually <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr3_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr3pathog" rid-ob="figobcraniosynostosisTselectedfgfr3pathog">p.Ala391Glu</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 10.</p></div></dd><dt>10. </dt><dd><div id="craniosynostosis.TF.3.10"><p class="no_margin">The <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Pro250Arg is a defining feature of <a href="/books/n/gene/muenke/">Muenke syndrome</a> [<a class="bk_pop" href="#craniosynostosis.REF.muenke.1997.555">Muenke et al 1997</a>].</p></div></dd></dl></div></div></div></div><div id="craniosynostosis.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><p>Note: <i>FGFR1</i>, <i>FGFR2</i>, and <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> has high <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> for Apert syndrome and the <i>FGFR</i>-related craniosynostosis syndromes in which craniosynostosis is an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> finding (i.e., <i>FGFR2</i>-related isolated coronal synostosis and Muenke syndrome). The sensitivity of molecular testing is lower for the other disorders; its primary utility is in confirming questionable clinical diagnoses. The yield of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is higher in bilateral than unilateral coronal synostosis [<a class="bk_pop" href="#craniosynostosis.REF.mulliken.2004.1899">Mulliken et al 2004</a>].</p><ul><li class="half_rhythm"><div><b>Most <i>FGFR</i>-related craniosynostosis syndromes.</b> An algorithm to increase efficiency and cost-effectiveness of molecular testing in craniosynostosis disorders involves initial performance of targeted analysis for recurrent pathogenic variants as listed below, followed by selective <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> sequencing [<a class="bk_pop" href="#craniosynostosis.REF.chun.2003.470">Chun et al 2003</a>].</div><ul><li class="half_rhythm"><div><b>Apert syndrome.</b> Targeted analysis of <i>FGFR2</i> for the pathogenic variants <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Ser252Trp</a> and <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Pro253Arg</a>. If normal, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> for rare <i>FGFR2</i> pathogenic variants or partial-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> insertions/deletions [<a class="bk_pop" href="#craniosynostosis.REF.bochukova.2009.204">Bochukova et al 2009</a>].</div></li><li class="half_rhythm"><div><b>Crouzon syndrome</b> or <b>Pfeiffer syndrome.</b> Sequence analysis of exons 8 and 10 (in which approximately 80% of <i>FGFR2</i> pathogenic variants are located) [<a class="bk_pop" href="#craniosynostosis.REF.kan.2002.472">Kan et al 2002</a>, <a class="bk_pop" href="#craniosynostosis.REF.passosbueno.2008.107">Passos-Bueno et al 2008</a>]. If normal, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>FGFR2</i> exons 3, 5, 11, 14, 15, 16, and 17 (in which an additional 10% of pathogenic variants are located) and targeted analysis for the <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr3_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr3pathog" rid-ob="figobcraniosynostosisTselectedfgfr3pathog">p.Pro250Arg</a>. Consider <i>FGFR1</i> testing for Pfeiffer syndrome if a pathogenic variant in <i>FGFR2</i> is not identified and/or the patient has a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</div></li></ul></li><li class="half_rhythm"><div><b>Crouzon syndrome with acanthosis nigricans</b> (AN) is usually caused by the <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr3_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr3pathog" rid-ob="figobcraniosynostosisTselectedfgfr3pathog">p.Ala391Glu</a>; therefore, such testing is warranted before testing for <i>FGFR2</i> pathogenic variants in a young child with Crouzon syndrome and either AN or other characteristic findings that include: choanal atresia; hydrocephalus; cranial features of Crouzon syndrome; and subtle skeletal features (narrow sacrosciatic notches; short vertebral bodies; lack of the normal increase in interpediculate distance from the upper lumbar vertebrae caudally; and broad, short metacarpals and phalanges) [<a class="bk_pop" href="#craniosynostosis.REF.schweitzer.2001.75">Schweitzer et al 2001</a>].</div><ul><li class="half_rhythm"><div>If testing is performed on a child with features of Crouzon syndrome during the first year of life (before the usual onset of AN), it is reasonable to test for <i>FGFR2</i> and <i>FGFR3</i> pathogenic variants concurrently.</div></li><li class="half_rhythm"><div>Testing for the <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Ala391Glu in a child older than age two years with Crouzon syndrome features without AN is likely to have a low yield.</div></li></ul></li><li class="half_rhythm"><div><b>Muenke syndrome</b> requires the combination of unilateral coronal synostosis or megalencephaly without craniosynostosis and identification of the p.Pro250Arg <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR3</i>.</div></li><li class="half_rhythm"><div><b><i>FGFR2</i>-related <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> coronal synostosis</b> requires the combination of uni- or bicoronal craniosynostosis and a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR2</i>.</div></li></ul><p><b>Predictive testing</b> for at-risk asymptomatic adult family members requires prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p><p><b>Prenatal diagnosis and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD)</b> for at-risk pregnancies require prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family. Note: Prenatal diagnosis of various craniosynostosis syndromes may be possible if physical findings are apparent on prenatal imaging (see <a href="#craniosynostosis.Prenatal_Testing_and_Pr">Prenatal Testing</a>).</p></div></div><div id="craniosynostosis.Clinical_Characteristic"><h2 id="_craniosynostosis_Clinical_Characteristic_">Clinical Characteristics</h2><div id="craniosynostosis.Clinical_Description"><h3>Clinical Description</h3><p>The abnormal skull shape in the <i>FGFR</i>-related craniosynostosis syndromes is usually noted in the newborn period; occasionally, it may be detected either prenatally by ultrasound examination or not until later in infancy. Because the skull grows in planes perpendicular to the cranial sutures, premature suture closure causes skull growth to cease in the plane perpendicular to the closed suture and to precede parallel to the suture. The skull shape becomes asymmetric, with the shape depending on which suture(s) is (are) closed. Coronal craniosynostosis causes the skull to be turribrachycephalic, or "tower shaped." Occasionally, cloverleaf skull (called <i>Kleeblatsch&#x000e4;del)</i> is seen. Cloverleaf skull involves a trilobar skull deformity usually caused by synostosis of coronal, lambdoidal, metopic, and sagittal sutures. The brain protrudes through open anterior and parietal fontanels.</p><p>The characteristic facial features shared by all of the <i>FGFR</i>-related craniosynostosis syndromes (except <a href="/books/n/gene/muenke/">Muenke</a> and <i>FGFR2</i>-related <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> coronal synostosis) include: ocular hypertelorism, proptosis, midface hypoplasia, small beaked nose, and prognathism. A high-arched palate is often present; more rarely, a cleft palate is present [<a class="bk_pop" href="#craniosynostosis.REF.stoler.2009.1375">Stoler et al 2009</a>]. Choanal stenosis or atresia can be seen, as well as sensorineural hearing loss and visual problems including strabismus. Cloverleaf skull is accompanied by midface hypoplasia, downslanting palpebral fissures, and extreme proptosis; in addition, developmental delay and/or intellectual disability, hydrocephalus, Chiari type 1 malformation [<a class="bk_pop" href="#craniosynostosis.REF.ranger.2010.427">Ranger et al 2010</a>], hearing loss [<a class="bk_pop" href="#craniosynostosis.REF.honnebier.2008.919">Honnebier et al 2008</a>], and visual impairment are common.</p><p>Breathing problems can occur in the first few months of life because of upper-airway obstruction related to the midface hypoplasia and associated choanal atresia or stenosis [<a class="bk_pop" href="#craniosynostosis.REF.chen.2008.165">Chen et al 2008</a>]. In severe cases, these problems may present as life-threatening respiratory failure [<a class="bk_pop" href="#craniosynostosis.REF.freeman.2008.223">Freeman et al 2008</a>] or as failure to thrive resulting from poor feeding. In either case, tracheostomy is often needed.</p><p>Non-communicating hydrocephalus is another complication that can result in neurologic impairment or death if not diagnosed and treated at an early stage. The risk of intracranial hypertension is greatest in Crouzon syndrome [<a class="bk_pop" href="#craniosynostosis.REF.lajeunie.2000.159">Lajeunie et al 2000</a>, <a class="bk_pop" href="#craniosynostosis.REF.renier.2000b.645">Renier et al 2000b</a>].</p><p>Chiari malformation may either be <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or acquired as a consequence of the skull deformities and other associated intracranial factors in individuals with craniosynostosis [<a class="bk_pop" href="#craniosynostosis.REF.ranger.2010.427">Ranger et al 2010</a>].</p><p>Even if every medical complication is managed promptly, a proportion of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children develop intellectual disability and neurologic problems. The greatest risk for intellectual disability is found in individuals with Apert syndrome [<a class="bk_pop" href="#craniosynostosis.REF.renier.1996.66">Renier et al 1996</a>, <a class="bk_pop" href="#craniosynostosis.REF.lajeunie.2000.159">Lajeunie et al 2000</a>].</p><p>Overall, the risk for significant problems depends on the associated anomalies in the individual rather than on the specific syndrome.</p><p>Specific clinical features of each of the <i>FGFR</i>-related craniosynostosis syndromes are summarized below.</p><p><b>Crouzon syndrome</b></p><ul><li class="half_rhythm"><div><b>Intellect.</b> Normal</div></li><li class="half_rhythm"><div><b>Craniofacial.</b> Significant proptosis, external strabismus, mandibular prognathism</div></li><li class="half_rhythm"><div><b>Extremities.</b> Normal (although radiographic metacarpal-phalangeal profile may reveal shortening) [<a class="bk_pop" href="#craniosynostosis.REF.murdochkinch.1997.61">Murdoch-Kinch &#x00026; Ward 1997</a>]</div></li><li class="half_rhythm"><div><b>Other.</b> Progressive hydrocephalus (30%), often with tonsillar herniation. Sacrococcygeal tail has also been described [<a class="bk_pop" href="#craniosynostosis.REF.lapunzina.2005.61">Lapunzina et al 2005</a>].</div></li></ul><p><b>Crouzon syndrome with acanthosis nigricans (AN)</b></p><ul><li class="half_rhythm"><div><b>Intellect.</b> Normal</div></li><li class="half_rhythm"><div><b>Craniofacial.</b> Significant proptosis, external strabismus, mandibular prognathism</div></li><li class="half_rhythm"><div><b>Extremities.</b> Normal (although radiographic metacarpal-phalangeal profile may reveal shortening) [<a class="bk_pop" href="#craniosynostosis.REF.murdochkinch.1997.61">Murdoch-Kinch &#x00026; Ward 1997</a>]</div></li><li class="half_rhythm"><div><b>Cutaneous.</b> The 5% of individuals with Crouzon syndrome who have AN (pigmentary changes in the skin fold regions) are said to have Crouzon syndrome with AN. AN can be present in the neonatal period or appear later.</div></li></ul><p><a href="/books/n/gene/apert/"><b>Apert syndrome</b></a></p><ul><li class="half_rhythm"><div><b>Intellect.</b> Varying degrees of developmental delay / intellectual disability (50%), possibly related to the timing of craniofacial surgery [<a class="bk_pop" href="#craniosynostosis.REF.renier.1996.66">Renier et al 1996</a>]</div></li><li class="half_rhythm"><div><b>Craniofacial.</b> Turribrachycephalic skull shape; moderate-to-severe midface hypoplasia</div></li><li class="half_rhythm"><div><b>Extremities.</b> Soft tissue and bony ("mitten glove") syndactyly of fingers and toes involving variable number of digits; occasional rhizomelic shortening, elbow ankylosis</div></li><li class="half_rhythm"><div><b>Other.</b> Fused cervical vertebrae (68%), usually C5-C6; hydrocephalus (2%); occasional internal organ anomalies such as cardiac and gastrointestinal defects [<a class="bk_pop" href="#craniosynostosis.REF.cohen.1993.758">Cohen &#x00026; Kreiborg 1993</a>, <a class="bk_pop" href="#craniosynostosis.REF.zarate.2010.638">Zarate et al 2010</a>]; ovarian dysgerminoma [<a class="bk_pop" href="#craniosynostosis.REF.rouzier.2008.696">Rouzier et al 2008</a>]</div></li></ul><p><b>Pfeiffer syndrome.</b> Pfeiffer syndrome has been subdivided into three clinical types [<a class="bk_pop" href="#craniosynostosis.REF.cohen.1993.300">Cohen 1993</a>]; types 2 and 3 are more common and more severe than type 1.</p><p><b>Pfeiffer syndrome type 1</b></p><ul><li class="half_rhythm"><div><b>Intellect.</b> Usually normal</div></li><li class="half_rhythm"><div><b>Craniofacial.</b> Moderate-to-severe midface hypoplasia</div></li><li class="half_rhythm"><div><b>Extremities.</b> Broad and medially deviated thumbs and great toes; variable degree of brachydactyly. In one family, reported involvement of the feet was the only abnormality [<a class="bk_pop" href="#craniosynostosis.REF.rossi.2003.269">Rossi et al 2003</a>].</div></li><li class="half_rhythm"><div><b>Other.</b> Hearing loss and hydrocephalus can be seen. Overall prognosis is more favorable than in Pfeiffer syndrome types 2 and 3.</div></li></ul><p><b>Pfeiffer syndrome type 2</b></p><ul><li class="half_rhythm"><div><b>Intellect.</b> Developmental delay / intellectual disability common</div></li><li class="half_rhythm"><div><b>Craniofacial.</b> Cloverleaf skull, extreme proptosis (often unable to close eyelids)</div></li><li class="half_rhythm"><div><b>Extremities.</b> Broad and medially deviated thumbs and great toes; ankylosis of elbows, knees; variable degree of brachydactyly</div></li><li class="half_rhythm"><div><b>Other.</b> Choanal stenosis/atresia, laryngotracheal abnormalities, cleft palate [<a class="bk_pop" href="#craniosynostosis.REF.stoler.2009.1375">Stoler et al 2009</a>]; hydrocephalus; seizures; sacrococcygeal eversion/appendage [<a class="bk_pop" href="#craniosynostosis.REF.oliveira.2006.629">Oliveira et al 2006</a>, <a class="bk_pop" href="#craniosynostosis.REF.lai.2008.73">Lai et al 2008</a>]; increased risk for early death</div></li></ul><p><b>Pfeiffer syndrome type 3</b></p><ul><li class="half_rhythm"><div><b>Intellect.</b> Developmental delay / intellectual disability common</div></li><li class="half_rhythm"><div><b>Craniofacial.</b> Turribrachycephalic skull shape, extreme proptosis (often unable to close eyelids)</div></li><li class="half_rhythm"><div><b>Extremities.</b> Broad and medially deviated thumbs and great toes; ankylosis of elbows, knees; variable degree of brachydactyly</div></li><li class="half_rhythm"><div><b>Other.</b> Choanal stenosis/atresia, laryngotracheal abnormalities; hydrocephalus; seizures, increased risk for early death</div></li></ul><p><a href="/books/n/gene/muenke/"><b>Muenke syndrome</b></a><b>.</b> Phenotypic overlap occurs with Pfeiffer, Jackson-Weiss, and Saethre-Chotzen syndromes. Some individuals with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have no clinically apparent abnormalities and are identified only on clinical, radiographic, or molecular genetic evaluation after they give birth to an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child.</p><ul><li class="half_rhythm"><div><b>Intellect.</b> Normal to mild intellectual disability</div></li><li class="half_rhythm"><div><b>Craniofacial.</b> Variable. Uni- or bilateral coronal craniosynostosis, or only megalencephaly; mild to significant midface hypoplasia; ocular hypertelorism. Unicoronal synostosis is more frequently seen in males [<a class="bk_pop" href="#craniosynostosis.REF.honnebier.2008.919">Honnebier et al 2008</a>].</div></li><li class="half_rhythm"><div><b>Extremities.</b> Variable. Carpal-tarsal fusion is diagnostic when present but is not always present; brachydactyly, carpal bone malsegregation, or coned epiphyses may occur.</div></li><li class="half_rhythm"><div><b>Other.</b> Bilateral, symmetric, low- to mid-frequency sensorineural hearing loss [<a class="bk_pop" href="#craniosynostosis.REF.honnebier.2008.919">Honnebier et al 2008</a>]; osteochondroma [<a class="bk_pop" href="#craniosynostosis.REF.barbosa.2009.260">Barbosa et al 2009</a>]</div></li></ul><p><b>Jackson-Weiss syndrome</b></p><ul><li class="half_rhythm"><div><b>Intellect.</b> Normal</div></li><li class="half_rhythm"><div><b>Craniofacial.</b> Mandibular prognathism</div></li><li class="half_rhythm"><div><b>Extremities.</b> Broad and medially deviated great toes, with normal hands; short first metatarsal, calcaneocuboid fusion, abnormally formed tarsals</div></li></ul><p><b>Beare-Stevenson cutis gyrata</b></p><p><b>Intellect.</b> Intellectual disability present in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</p><p><b>Craniofacial.</b> Moderate-to-severe midface hypoplasia; abnormal ears, natal teeth</p><ul><li class="half_rhythm"><div><b>Extremities.</b> Normal; furrowed palms and soles</div></li><li class="half_rhythm"><div><b>Cutaneous.</b> Widespread cutis gyrata and AN, which are usually evident at birth; skin tags, prominent umbilical stump, accessory nipples</div></li><li class="half_rhythm"><div><b>Genital.</b> Bifid scrotum, prominent labial raphe, rugated labia majora</div></li><li class="half_rhythm"><div><b>Other.</b> Pyloric stenosis; anterior anus</div></li></ul><p><b><i>FGFR2</i>-related <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> coronal synostosis</b></p><ul><li class="half_rhythm"><div><b>Intellect.</b> Normal</div></li><li class="half_rhythm"><div><b>Craniofacial.</b> Unilateral coronal synostosis</div></li><li class="half_rhythm"><div><b>Extremities.</b> Normal</div></li></ul></div><div id="craniosynostosis.GenotypePhenotype_Corre"><h3>Genotype-Phenotype Correlations</h3><p>A wide phenotypic range has been described among individuals with identical pathogenic variants in <i>FGFR2</i> [<a class="bk_pop" href="#craniosynostosis.REF.mulliken.1999.1603">Mulliken et al 1999</a>, <a class="bk_pop" href="#craniosynostosis.REF.ito.2005.23">Ito et al 2005</a>]. Pathogenic variants in <i>FGFR2</i> or <i>FGFR3</i> can give rise to either bilateral or unilateral coronal synostosis, even in the same family [<a class="bk_pop" href="#craniosynostosis.REF.mulliken.2004.1899">Mulliken et al 2004</a>]. In a study of 47 individuals with unilateral coronal synostosis (also known as synostotic frontal plagiocephaly), asymmetric brachycephaly and orbital hypertelorism were strongly correlated with identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR2</i>, <i>FGFR3</i>, or <i>TWIST1</i> (formerly <i>TWIST</i>) [<a class="bk_pop" href="#craniosynostosis.REF.mulliken.2004.1899">Mulliken et al 2004</a>].</p><p>One specific <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation is the association of the <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr3_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr3pathog" rid-ob="figobcraniosynostosisTselectedfgfr3pathog">p.Ala391Glu</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR3</i> in individuals with Crouzon syndrome and AN. Individuals with Crouzon syndrome who do not have AN are unlikely to have a pathogenic variant in <i>FGFR3</i>.</p><p>Cleft palate, severe ocular problems (strabismus, ptosis, astigmatism, and amblyopia), nasolacrimal stenosis, and possibly humeroradial synostosis are more common in individuals with the <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Ser252Trp</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR2</i> [<a class="bk_pop" href="#craniosynostosis.REF.akai.2006.108">Akai et al 2006</a>], whereas the degree of syndactyly and intellectual disability is more prominent in individuals with the <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Pro253Arg</a> pathogenic variant in <i>FGFR2</i> [<a class="bk_pop" href="#craniosynostosis.REF.slaney.1996.923">Slaney et al 1996</a>, <a class="bk_pop" href="#craniosynostosis.REF.lajeunie.1999.443">Lajeunie et al 1999</a>, <a class="bk_pop" href="#craniosynostosis.REF.kanauchi.2003.302">Kanauchi et al 2003</a>, <a class="bk_pop" href="#craniosynostosis.REF.jadico.2006.521">Jadico et al 2006</a>]. Individuals with Apert syndrome and the p.Pro253Arg pathogenic variant have a more improved craniofacial appearance following craniofacial surgery [<a class="bk_pop" href="#craniosynostosis.REF.von_gernet.2000.137">von Gernet et al 2000</a>].</p><p>Pathogenic variants seen in individuals with Crouzon, Pfeiffer, and Jackson-Weiss syndromes occur in and around the B <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> of the third immunoglobulin-like <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> in <i>FGFR2</i>.</p><p>Identical pathogenic variants have been seen in individuals with Crouzon, Pfeiffer, and Jackson-Weiss syndromes [<a class="bk_pop" href="#craniosynostosis.REF.hollway.1997.251">Hollway et al 1997</a>, <a class="bk_pop" href="#craniosynostosis.REF.oldridge.1997.137">Oldridge et al 1997</a>], suggesting that unlinked modifier genes or epigenetic factors play a role in determining the final <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Interestingly, two <i>FGFR2</i> pathogenic variants creating cysteine residues (<a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Trp290Cys</a> and <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Tyr340Cys</a>) cause severe forms of Pfeiffer syndrome whereas conversion of the same residues into another amino acid (<a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Trp290Gly</a>, <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Trp290Arg</a>, <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Tyr340His</a>) results exclusively in the Crouzon syndrome phenotype [<a class="bk_pop" href="#craniosynostosis.REF.lajeunie.2006.289">Lajeunie et al 2006</a>].</p><p>Pfeiffer syndrome-causing variants <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Ser351Cys</a>, p.Trp290Cys, and <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Cys342Arg</a> in <i>FGFR2</i> have been associated with severe phenotypes including cloverleaf skull, severe exophthalmia, midface flattening, hydrocephalus requiring ventriculoperitoneal shunt, radio-ulnar-humeral synostosis, fusion of the cartilaginous tracheal rings (tracheal sleeve), <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or acquired Chiari malformation, and frequently premature death [<a class="bk_pop" href="#craniosynostosis.REF.zackai.2003.209">Zackai et al 2003</a>, <a class="bk_pop" href="#craniosynostosis.REF.hockstein.2004.1298">Hockstein et al 2004</a>, <a class="bk_pop" href="#craniosynostosis.REF.gonzales.2005.179">Gonzales et al 2005</a>, <a class="bk_pop" href="#craniosynostosis.REF.akai.2006.108">Akai et al 2006</a>, <a class="bk_pop" href="#craniosynostosis.REF.lajeunie.2006.289">Lajeunie et al 2006</a>, <a class="bk_pop" href="#craniosynostosis.REF.oliveira.2006.629">Oliveira et al 2006</a>, <a class="bk_pop" href="#craniosynostosis.REF.stevens.2006.187">Stevens &#x00026; Roeder 2006</a>, <a class="bk_pop" href="#craniosynostosis.REF.chen.2008.165">Chen et al 2008</a>, <a class="bk_pop" href="#craniosynostosis.REF.ranger.2010.427">Ranger et al 2010</a>].</p><p>Three individuals were reported to have clinical features of Crouzon, Pfeiffer, or Apert syndromes, but had pathogenic variants in both <i>FGFR2</i> and <i>TWIST1</i> [<a class="bk_pop" href="#craniosynostosis.REF.anderson.2006.166">Anderson et al 2006</a>].</p></div><div id="craniosynostosis.Penetrance"><h3>Penetrance</h3><p><i>FGFR</i>-related coronal synostosis is usually <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> with reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p><p>Jackson-Weiss, Apert, and Pfeiffer syndromes show complete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p><p>Crouzon syndrome typically implies complete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>; however, in one family a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was associated with <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> and reduced penetrance [<a class="bk_pop" href="#craniosynostosis.REF.de_ravel.2005.503">de Ravel et al 2005</a>].</p></div><div id="craniosynostosis.Anticipation"><h3>Anticipation</h3><p>Anticipation has not been reported in the <i>FGFR</i>-related craniosynostosis syndromes.</p></div><div id="craniosynostosis.Nomenclature"><h3>Nomenclature</h3><p>Adelaide-type craniosynostosis, a term to describe Muenke syndrome, is no longer used.</p></div><div id="craniosynostosis.Prevalence"><h3>Prevalence</h3><p>The overall incidence for all forms of craniosynostosis is 1:2,000-1:2,500 live births.</p><p>The incidence of coronal synostosis is 1:16,000 in males and 1:8,000 in females; the overall contribution of <i>FGFR</i> mutation to the incidence of craniosynostosis is unknown.</p><p>The incidence of Crouzon syndrome is 1.6:100,000; that of Apert syndrome is 1:100,000; the combined incidence of the Pfeiffer syndromes is 1:100,000.</p></div></div><div id="craniosynostosis.Genetically_Related_All"><h2 id="_craniosynostosis_Genetically_Related_All_">Genetically Related (Allelic) Disorders</h2><p>Pathogenic variants in <i>FGFR1</i>, <i>FGFR2</i>, and <i>FGFR3</i> are responsible for a number of clinically distinct disorders.</p><p><b><i>FGFR1</i></b></p><ul><li class="half_rhythm"><div><b>Osteoglophonic dysplasia</b> is a skeletal dysplasia syndrome that shares characteristics with craniosynostosis syndromes and dwarfing syndromes. Features include craniosynostosis, prominent supraorbital ridge, depressed nasal root, rhizomelic dwarfism, and characteristic non-osseous bone lesions [<a class="bk_pop" href="#craniosynostosis.REF.white.2005.361">White et al 2005</a>]. The identification of <i>FGFR1</i> pathogenic variants demonstrates that FGFR1 may function as a negative regulator of long bone development rather than increasing skull bone growth [<a class="bk_pop" href="#craniosynostosis.REF.white.2005.361">White et al 2005</a>, <a class="bk_pop" href="#craniosynostosis.REF.farrow.2006.537">Farrow et al 2006</a>].</div></li><li class="half_rhythm"><div>An <i>FGFR1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr1_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr1pathog" rid-ob="figobcraniosynostosisTselectedfgfr1pathog">p.Pro252Arg</a>) has been reported in three kindreds with the classic hand and foot findings of Pfeiffer syndrome but without craniosynostosis or craniofacial features [<a class="bk_pop" href="#craniosynostosis.REF.hackett.2006.207">Hackett &#x00026; Rowe 2006</a>].</div></li><li class="half_rhythm"><div>Autosomal dominant <a href="/books/n/gene/kms/">Kallmann syndrome</a> can be caused by mutation of <i>FGFR1</i> [<a class="bk_pop" href="#craniosynostosis.REF.villanueva.2010.51">Villanueva &#x00026; de Roux 2010</a>]; <i>FGFR1</i> pathogenic variants were also found in approximately 10% of people with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> <a href="/books/n/gene/kms/">isolated hypogonadotropic hypogonadism</a> with and without anosmia [<a class="bk_pop" href="#craniosynostosis.REF.trarbach.2006.4006">Trarbach et al 2006</a>].</div></li></ul><p><b><i>FGFR2</i></b></p><ul><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> scaphocephaly syndrome characterized by scaphocephaly, macrocephaly, midface flattening, and mild intellectual disabilities has been reported in a three-generation kindred with a <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Lys526Glu</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR2</i>. This variant resides in the tyrosine kinase-1 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, which is located outside the typical mutational <a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a> of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> seen in other craniosynostosis syndromes [<a class="bk_pop" href="#craniosynostosis.REF.mcgillivray.2005.656">McGillivray et al 2005</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/scs/"><b>Saethre-Chotzen syndrome</b></a> is typically caused by mutation of <i>TWIST1</i>, but a family with phenotypic features of Saethre-Chotzen syndrome and normal <i>TWIST1</i> <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> had the <i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Gln289Pro</a> [<a class="bk_pop" href="#craniosynostosis.REF.freitas.2006.142">Freitas et al 2006</a>].</div></li><li class="half_rhythm"><div><b>Syndromic craniosynostosis with elbow contracture.</b> The <i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Ser351Cys</a> has been reported in approximately eight individuals with severe craniosynostosis, midface hypoplasia, elbow joint contracture, developmental delays, and often premature death [<a class="bk_pop" href="#craniosynostosis.REF.akai.2006.108">Akai et al 2006</a>].</div></li></ul><p><b><i>FGFR3</i></b></p><ul><li class="half_rhythm"><div><a href="/books/n/gene/achondroplasia/"><b>Achondroplasia</b></a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/hypochondroplasia/"><b>Hypochondroplasia</b></a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/td/"><b>Thanatophoric dysplasia</b></a></div></li><li class="half_rhythm"><div><b>Camptodactyly, tall stature, scoliosis, and hearing loss (CATSHL) syndrome</b> is caused by a <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr3_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr3pathog" rid-ob="figobcraniosynostosisTselectedfgfr3pathog">p.Arg621His</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the <i>FGFR3</i> tyrosine kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> that leads to decreased protein function, indicating that pathogenic variants in <i>FGFR3</i> can either hinder or promote bone growth [<a class="bk_pop" href="#craniosynostosis.REF.toydemir.2006.935">Toydemir et al 2006</a>].</div></li></ul><p>Note: <i>FGFR3</i> pathogenic variants were reported in two individuals with both <a href="/books/n/gene/muenke/">Muenke syndrome</a> and hypochondroplasia. Both were cognitively normal but had early-onset temporal lobe seizures and bilateral dysgenesis of the medial temporal lobes [<a class="bk_pop" href="#craniosynostosis.REF.grosso.2003.88">Grosso et al 2003</a>].</p></div><div id="craniosynostosis.Differential_Diagnosis"><h2 id="_craniosynostosis_Differential_Diagnosis_">Differential Diagnosis</h2><div id="craniosynostosis.Primary_Craniosynostosi"><h3>Primary Craniosynostosis</h3><p>Primary craniosynostosis needs to be distinguished from secondary craniosynostosis. In primary craniosynostosis, abnormal biology of the suture causes premature suture closure, as in the <i>FGFR</i>-related craniosynostoses; in secondary craniosynostosis, the suture biology is normal, but abnormal external forces result in premature suture closure. In children with deficient brain growth, all cranial sutures fuse and the head is symmetric and microcephalic. Abnormal head positioning in utero or in infancy may produce an abnormal skull shape (plagiocephaly); the abnormality often resolves with appropriate head positioning but occasionally results in craniosynostosis [<a class="bk_pop" href="#craniosynostosis.REF.hunt.1996.127">Hunt &#x00026; Puczynski 1996</a>, <a class="bk_pop" href="#craniosynostosis.REF.kane.1996.877">Kane et al 1996</a>].</p><p>In individuals with primary craniosynostosis it is important to determine which cranial sutures are involved and whether the craniosynostosis is an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> finding or part of a syndrome.</p><ul><li class="half_rhythm"><div><b>Lambdoidal or sagittal synostosis</b> suggests a diagnosis other than <i>FGFR</i>-related craniosynostoses, even in the presence of hand and foot anomalies (e.g., sagittal synostosis and cutaneous hand and foot syndactyly in Philadelphia-type craniosynostosis [<a class="bk_pop" href="#craniosynostosis.REF.robin.1996.184">Robin et al 1996</a>]).</div></li><li class="half_rhythm"><div><b>Metopic synostosis,</b> which causes trigonocephaly, is usually an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> finding, but may be part of a more complex disorder in which progressive involvement of other sutures occurs [<a class="bk_pop" href="#craniosynostosis.REF.tartaglia.1999.389">Tartaglia et al 1999</a>]. Therefore, <i>FGFR</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is not warranted in individuals with isolated trigonocephaly, but is a consideration in individuals with trigonocephaly in whom other craniofacial anomalies are seen. A study in individuals with either <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> or nonsyndromic metopic craniosynostosis found no pathogenic variants in <i>FGFR1</i>, <i>CER1</i>, or <i>CDON</i>, suggesting that analysis of these genes is not warranted in persons with these findings [<a class="bk_pop" href="#craniosynostosis.REF.jehee.2006.148">Jehee et al 2006</a>].</div></li></ul></div><div id="craniosynostosis.Isolated_Craniosynostos"><h3>Isolated Craniosynostosis</h3><p>Isolated craniosynostosis (i.e., craniosynostosis occurring without other anomalies) accounts for the vast majority of craniosynostosis. Only rarely is <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> craniosynostosis <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a>, but in such cases it is usually <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> with reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, with the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> dependent on which suture is involved [<a class="bk_pop" href="#craniosynostosis.REF.cohen.1996.503">Cohen 1996</a>, <a class="bk_pop" href="#craniosynostosis.REF.lajeunie.1996.282">Lajeunie et al 1996</a>].</p><p>The incidence of <i>FGFR3</i> pathogenic variants in individuals with apparently <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> coronal craniosynostosis is not known.</p><ul><li class="half_rhythm"><div>One study found an <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in four of 37 individuals with nonsyndromic coronal craniosynostosis; in three of the four individuals, the father had the <i>FGFR3</i> pathogenic variant [<a class="bk_pop" href="#craniosynostosis.REF.gripp.1998.714">Gripp et al 1998</a>].</div></li><li class="half_rhythm"><div>In another study, 29 of 76 individuals with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> coronal synostosis had the <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr3_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr3pathog" rid-ob="figobcraniosynostosisTselectedfgfr3pathog">p.Pro250Arg</a>.</div></li><li class="half_rhythm"><div>In another study, eight of 47 individuals with unilateral coronal synostosis had identifiable pathogenic variants, including two in <i>FGFR2</i>, three in <i>FGFR3</i>, and three in <i>TWIST1</i> [<a class="bk_pop" href="#craniosynostosis.REF.mulliken.2004.1899">Mulliken et al 2004</a>]. Therefore, testing of all individuals with either unilateral or bilateral coronal craniosynostosis for <i>FGFR2</i> or <i>FGFR3</i> pathogenic variants is probably warranted, particularly if asymmetric brachycephaly and/or orbital hypertelorism are present [<a class="bk_pop" href="#craniosynostosis.REF.renier.2000a.631">Renier et al 2000a</a>].</div></li></ul></div><div id="craniosynostosis.Syndromic_Craniosynosto"><h3>Syndromic Craniosynostosis</h3><p>Craniosynostosis is a finding in more than 150 genetic disorders. Additional syndromes that should be considered:</p><p><a href="/books/n/gene/scs/"><b>Saethre-Chotzen syndrome</b></a><b>.</b> Classic Saethre-Chotzen syndrome is characterized by coronal synostosis (unilateral or bilateral), facial asymmetry (particularly in individuals with unicoronal synostosis), ptosis, and characteristic appearance of the ear (small pinna with a prominent crus). Syndactyly of digits two and three of the hand is variably present. Although mild to moderate developmental delay and intellectual disability have been reported, normal intelligence is more common. Less common manifestations of Saethre-Chotzen syndrome include short stature, parietal foramina, radioulnar synostosis, cleft palate, maxillary hypoplasia, ocular hypertelorism, hallux valgus, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart malformations. The diagnosis of Saethre-Chotzen syndrome is made primarily on clinical findings. Pathogenic variants in <i>TWIST1</i> are causative. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p><p>Several features are shared by Saethre-Chotzen syndrome and Muenke syndrome. However, persons with Saethre-Chotzen syndrome with a <i>TWIST1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> typically have a lower frontal hairline, worsening ptosis, soft-tissue syndactyly, hallux valgus, and increased cranial pressure resulting from early suture fusion. Persons with Muenke syndrome have an increased frequency of hearing loss and mental disabilities [<a class="bk_pop" href="#craniosynostosis.REF.kress.2006.39">Kress et al 2006</a>]. The clinical diagnosis of Saethre-Chotzen syndrome has also been reported in a family with an <i>FGFR2</i> pathogenic variant (<a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTselectedfgfr2pathog" rid-ob="figobcraniosynostosisTselectedfgfr2pathog">p.Gln289Pro</a>), suggesting that the <i>TWIST1</i> and <i>FGFR</i> products may interact during development [<a class="bk_pop" href="#craniosynostosis.REF.freitas.2006.142">Freitas et al 2006</a>]. Testing for suspected Saethre-Chotzen syndrome should include analysis of <i>FGFR2</i>, <i>FGFR3</i>, and <i>TWIST1</i>.</p><p><b>Boston-type craniosynostosis.</b> From the 19 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in the one family reported to date [<a class="bk_pop" href="#craniosynostosis.REF.warman.1993.444">Warman et al 1993</a>], four general phenotypes emerged:</p><ul><li class="half_rhythm"><div>Type 1. Fronto-orbital recession (8 individuals)</div></li><li class="half_rhythm"><div>Type 2. Frontal bossing (2)</div></li><li class="half_rhythm"><div>Type 3. Turribrachycephaly as a result of coronal craniosynostosis (7)</div></li><li class="half_rhythm"><div>Type 4. Cloverleaf skull (2)</div></li></ul><p>Short first metatarsals are present. Headaches, seizures, myopia, and visual deficits may occur. Of note, some individuals who have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are asymptomatic. Mutation of <i>MSX2</i> is causative [<a class="bk_pop" href="#craniosynostosis.REF.ignelzi.2003.751">Ignelzi et al 2003</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, with complete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and variable expression.</p><p><a href="/books/n/gene/abs/"><b>Antley-Bixler syndrome</b></a> (trapezoidocephaly-multiple synostosis syndrome) is caused by a sterol biosynthesis defect and involves premature closure of the coronal and lambdoidal sutures, brachycephaly with frontal bossing, proptosis, downslanting palpebral fissures, severe depression of the nasal bridge (with or without choanal stenosis or atresia), and low-set, protruding ears. The main limb features are radiohumeral synostosis, medial bowing of the ulnae, bowing of the femurs, slender hands and feet, contractures at the proximal IP joints, fractures, and advanced bone age. Some individuals have <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease, renal anomalies, abnormalities of the female genitalia, and signs of congenital adrenal hyperplasia [<a class="bk_pop" href="#craniosynostosis.REF.bottero.1997.48">Bottero et al 1997</a>, <a class="bk_pop" href="#craniosynostosis.REF.williamson.2006.1797">Williamson et al 2006</a>]. Mutation of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding cytochrome P450 reductase (POR) is causative [<a class="bk_pop" href="#craniosynostosis.REF.adachi.2006.633">Adachi et al 2006</a>, <a class="bk_pop" href="#craniosynostosis.REF.marohnic.2006.35975">Marohnic et al 2006</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><a href="/books/n/gene/bgs/"><b>Baller-Gerold syndrome</b></a> is a craniosynostosis syndrome with radial aplasia. The craniosynostosis usually involves the coronal sutures but may affect multiple sutures. The radial defect may be asymmetric, resulting in aplasia on one side and hypoplasia on the other. The thumb can be absent and the ulna is usually short and curved. Carpal and metacarpal bones may be absent. Occasional findings include ocular hypertelorism, epicanthal folds, a prominent nasal bridge, midline capillary hemangiomas, genitourinary malformations, and intellectual disability. Identification of <i>RECQL4</i> pathogenic variants in two unrelated families supports the notion that Baller-Gerold syndrome is allelic to <a href="/books/n/gene/rts/">Rothmund-Thomson syndrome</a> and RAPADILINO syndrome, and that pathogenic variants in <i>RECQL4</i> cause a subset of Baller-Gerold syndrome [<a class="bk_pop" href="#craniosynostosis.REF.van_maldergem.2006.148">Van Maldergem et al 2006</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><b>Carpenter syndrome</b> (acrocephalopolysyndactyly type II) is a craniosynostosis syndrome with preaxial polydactyly of the feet. Brachydactyly, syndactyly, and aplasia or hypoplasia of the middle phalanges is present in the hands. Intellectual disability is variable. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is causative is <i>RAB23</i> [<a class="bk_pop" href="#craniosynostosis.REF.jenkins.2007.1162">Jenkins et al 2007</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><b>Craniofrontonasal syndrome</b> is characterized by premature closure of the coronal suture and frontonasal dysplasia. Features include severe ocular hypertelorism, a broad bifid nose, asymmetric frontal bossing, a low posterior hairline, anterior widow's peak, and occasionally a cleft lip and palate, neck webbing, rounded shoulders, abnormal clavicles, and raised scapulae. Longitudinal splitting of the nails occurs often, skin syndactyly is occasionally present, and the fingers and toes may be deviated distally or occasionally hypoplastic. Most children have normal intelligence. More females have been reported than males, with more severe manifestations in females [<a class="bk_pop" href="#craniosynostosis.REF.saavedra.1996.147">Saavedra et al 1996</a>]. Mutation of <i>EFNB1</i> is causative. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>.</p><p><a href="/books/n/gene/gcps/"><b>Greig cephalopolysyndactyly</b></a> features include high forehead with frontal bossing, macrocephaly, hypertelorism, broad nasal base, polydactyly of the hands (often postaxial), and feet with syndactyly of toes 1, 2, and 3 and often a duplicated hallux [<a class="bk_pop" href="#craniosynostosis.REF.biesecker.1997.259">Biesecker 1997</a>]. Mutation of <i>GLI3</i> is causative. Standard Giemsa-banding <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> studies may detect translocations or gross cytogenetic deletions involving 7p13. <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analysis detects deletions in the estimated 5%-10% of individuals with large deletions. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p><p><b>Opitz trigonencephaly C syndrome</b> is a multiple malformation syndrome with trigonocephaly. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is causative is not known, but one person has been reported to have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> balanced reciprocal <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> t(3;18)(q13.13;q12.1) [<a class="bk_pop" href="#craniosynostosis.REF.chinen.2006.1655">Chinen et al 2006</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><b>Philadelphia-type craniosynostosis,</b> featuring sagittal suture craniosynostosis with cutaneous hand and foot syndactyly, was identified in a single large kindred [<a class="bk_pop" href="#craniosynostosis.REF.robin.1996.184">Robin et al 1996</a>]. Duplications within and around <i>IHH</i> have been found in three families [<a class="bk_pop" href="#craniosynostosis.REF.klopocki.2011.70">Klopocki et al 2011</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p><p><a href="/books/n/gene/sgs/"><b>Shprintzen-Goldberg syndrome</b></a> (marfanoid-craniosynostosis syndrome) is characterized by craniosynostosis (involving the coronal, sagittal, or lambdoid sutures), distinctive craniofacial features, skeletal changes (dolichostenomelia, arachnodactyly, camptodactyly, pes planus, pectus excavatum or carinatum, scoliosis, joint hypermobility, or contractures), neurologic abnormalities, mild to moderate intellectual disability, and brain anomalies (hydrocephalus, dilatation of the lateral ventricles, and Chiari 1 malformation). Cardiovascular anomalies (mitral valve prolapse, mitral regurgitation, and aortic regurgitation) may occur. Minimal subcutaneous fat, abdominal wall defects, cryptorchidism in males, and myopia are also characteristic findings. The diagnosis is suspected in individuals with characteristic clinical findings and radiographic findings showing C1-C2 abnormality, wide anterior fontanel, thin ribs, 13 pairs of ribs, square-shaped vertebral bodies, and osteopenia. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is causative and the <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> are unknown.</p><p>Pathogenic variants of <i>TGFBR1</i> and <i>TGFBR2</i> (see <a href="/books/n/gene/loeys-dietz/">Loeys-Dietz Syndrome</a>) can also be associated with craniosynostosis, but this feature is not one of the major clinical characteristics of the corresponding syndromes, or occurs with low frequency [<a class="bk_pop" href="#craniosynostosis.REF.passosbueno.2008.107">Passos-Bueno et al 2008</a>].</p></div></div><div id="craniosynostosis.Management"><h2 id="_craniosynostosis_Management_">Management</h2><div id="craniosynostosis.Evaluations_Following_I"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with <i>FGFR</i>-related craniosynostosis, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Assessment for hydrocephalus by brain CT or MRI in all cases of <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> craniosynostosis, with close observation in those with pathogenic variants known to cause a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></div></li><li class="half_rhythm"><div>Assessment for upper-airway obstruction or tracheal sleeve (in <i>FGFR2</i>-related Pfeiffer syndrome)</div></li><li class="half_rhythm"><div>Assessment for exposure keratopathy</div></li><li class="half_rhythm"><div>Spinal x-rays to evaluate for vertebral anomalies</div></li><li class="half_rhythm"><div>Imaging of the gastrointestinal system in individuals with Pfeiffer or Apert syndrome for intestinal malrotation or esophageal atresia</div></li></ul></div><div id="craniosynostosis.Treatment_of_Manifestat"><h3>Treatment of Manifestations</h3><p><b>Craniofacial.</b> Children with any of the <i>FGFR</i>-related craniosynostosis syndromes benefit from the multidisciplinary team approach practiced in most craniofacial clinics affiliated with major pediatric medical centers. The specialists usually include plastic surgeons, neurosurgeons, otolaryngologists, and dentists as well as audiologists, speech pathologists, developmental pediatricians, social workers, and medical geneticists. The team can usually identify and address physical and developmental problems as well as psychosocial and other issues.</p><p>Individuals with <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> craniosynostosis usually require a series of staged surgical procedures; the number and type are tailored to the individual's needs [<a class="bk_pop" href="#craniosynostosis.REF.posnick.2000.433">Posnick &#x00026; Ruiz 2000</a>, <a class="bk_pop" href="#craniosynostosis.REF.honnebier.2008.919">Honnebier et al 2008</a>]. Three-dimensional skull CT can be used for morphologic mapping to help plan surgical treatment [<a class="bk_pop" href="#craniosynostosis.REF.binaghi.2000.856">Binaghi et al 2000</a>]. Some individuals with syndromic craniosynostosis require a dozen or more surgeries over a lifetime. Seldom is the correction perfect, but significant cosmetic improvement is often possible. Evidence suggests that the calvarial bone needed for these surgeries is often more brittle, thinner, and less robust than cranial bone from unaffected donors [<a class="bk_pop" href="#craniosynostosis.REF.tholpady.2004.431">Tholpady et al 2004</a>].</p><p>In contrast to children with nonsyndromic craniosynostosis, in whom the first surgery is usually performed between ages six months and one year, children with <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> craniosynostosis often have their first surgery as early as age three months. The procedure is a bilateral craniotomy with a fronto-orbital advancement to expand the cranial vault. Because the procedure leaves uncovered areas of dura that fill in by age 15-18 months, it must be performed before the child is 18 months old. In a series of 2,317 individuals who underwent surgery for craniosynostosis, improved cosmetic and functional results followed early surgery; no increased operative risk was seen in infants [<a class="bk_pop" href="#craniosynostosis.REF.lajeunie.2000.159">Lajeunie et al 2000</a>, <a class="bk_pop" href="#craniosynostosis.REF.renier.2000b.645">Renier et al 2000b</a>].</p><p>Distraction osteogenesis of the craniofacial skeleton and long bones of the extremities may be a less invasive alternative approach to bone grafting in some individuals. In addition, the distraction procedures can expand the overlying soft tissues simultaneously. The devices used for distraction of the mandible, midface, and cranium tend to be the buried type and made of absorbable materials; cytokine administration may shorten the consolidation period. The usefulness and appropriateness of the distraction procedure must be assessed for each disorder [<a class="bk_pop" href="#craniosynostosis.REF.matsumoto.2003.117">Matsumoto et al 2003</a>].</p><p>In some cases, other complications including hydrocephalus, upper-airway obstruction, and exposure keratopathy of the cornea may prompt even earlier craniotomy or fronto-orbital advancement, or other interventions including ventriculo-peritoneal stunting, tracheostomy, or surgical eyelid closure.</p><p>Timing of subsequent craniofacial surgeries influences their success. Procedures done prior to the cessation of growth in the particular facial region usually have poor long-term results and require additional operations.</p><p>Individuals with Apert syndrome have the highest incidence of repeat surgery to correct forehead contour [<a class="bk_pop" href="#craniosynostosis.REF.wong.2000.2314">Wong et al 2000</a>, <a class="bk_pop" href="#craniosynostosis.REF.thomas.2005.347">Thomas et al 2005</a>].</p><p><a class="bk_pop" href="#craniosynostosis.REF.wilkie.2010.e391">Wilkie et al [2010]</a> noted that children with craniosynostosis resulting from single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> pathogenic variants were more likely to require repeat surgery compared to individuals whose craniosynostosis was caused by a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> abnormality.</p><p><b>Spine.</b> Congenital spine anomalies can cause scoliosis and spinal injury and thus need immediate attention.</p><p><b>Limbs.</b> Surgical correction of limb defects is usually not possible because the skeletal anomalies are developmental and the structures have never formed normally.</p><ul><li class="half_rhythm"><div>In the mitten-glove syndactyly seen in Apert syndrome, surgical separation of the digits often provides relatively little functional improvement.</div></li><li class="half_rhythm"><div>With the elbow ankylosis seen in Pfeiffer syndrome types 2 and 3, some functional improvement can be gained by altering the angle at which the elbows are fixed. For example, in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, elbow contractures are at approximately the same angle, often so that an individual cannot reach the mouth easily with the hands or clean appropriately following toileting; functional improvement can be achieved if the angle of each arm is altered so that one arm is positioned for eating and the other for toileting.</div></li></ul></div><div id="craniosynostosis.Prevention_of_Secondary"><h3>Prevention of Secondary Complications</h3><p>The primary treatment of craniofacial abnormalities associated with craniosynostosis is surgical reconstruction. Early treatment may reduce the risk for secondary complications (e.g., hydrocephalus, cognitive impairment).</p><p>Patients with severe proptosis often require ophthalmologic lubrication to prevent exposure keratopathy.</p></div><div id="craniosynostosis.Surveillance"><h3>Surveillance</h3><p>Persons with a known risk for significant complications, including hydrocephalus, should be monitored from birth throughout life at intervals and by methods appropriate for the severity of the clinical findings.</p><p>Six of 29 persons with the <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Pro250Arg required reoperation for increased intracranial pressure, emphasizing the need for continued long-term monitoring [<a class="bk_pop" href="#craniosynostosis.REF.thomas.2005.347">Thomas et al 2005</a>].</p></div><div id="craniosynostosis.Evaluation_of_Relatives"><h3>Evaluation of Relatives at Risk</h3><p>At-risk relatives should be evaluated by clinical and radiographic criteria given that manifestations may not be readily evident in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. When the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is known in the family, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to evaluate relatives for the disorder. Early diagnosis may allow mildly affected relatives to benefit from early surveillance and intervention.</p><p>See <a href="#craniosynostosis.Related_Genetic_Counsel">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="craniosynostosis.Therapies_Under_Investi"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="craniosynostosis.Genetic_Counseling"><h2 id="_craniosynostosis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="craniosynostosis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>The <i>FGFR</i>-related craniosynostosis syndromes are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="craniosynostosis.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>An individual with <i>FGFR</i>-related craniosynostosis may have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent or may have the disease as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include clinical, radiographic, and molecular genetic evaluation.</div></li><li class="half_rhythm"><div>With a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, as can be seen in <a href="/books/n/gene/muenke/">Muenke syndrome</a>, Crouzon syndrome, Pfeiffer syndrome, and Jackson-Weiss syndrome, inheritance of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent is common; whereas in the most severe forms, <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> pathogenic variants are common.</div></li><li class="half_rhythm"><div>All cases of Pfeiffer syndrome 3 and Beare-Stevenson syndrome and all but one case of Pfeiffer syndrome 2 have resulted from a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a><i>.</i></div></li><li class="half_rhythm"><div>Advanced paternal age has been shown clinically to be associated with <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants for Crouzon syndrome, <a href="/books/n/gene/apert/">Apert syndrome</a>, Pfeiffer syndrome [<a class="bk_pop" href="#craniosynostosis.REF.glaser.2000.768">Glaser et al 2000</a>], Beare-Stevenson syndrome, and Muenke syndrome [<a class="bk_pop" href="#craniosynostosis.REF.rannaneliya.2004.200">Rannan-Eliya et al 2004</a>]. Paternal age effect in <i>de novo</i> mutation has been conclusively demonstrated at the molecular level in Apert syndrome [<a class="bk_pop" href="#craniosynostosis.REF.moloney.1996.48">Moloney et al 1996</a>, <a class="bk_pop" href="#craniosynostosis.REF.yoon.2009.e1000558">Yoon et al 2009</a>]. It has been proposed that <i>FGFR</i> pathogenic variants are paradoxically enriched in the male <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> because they confer a selective advantage to the spermatagonial cells in which they arise [<a class="bk_pop" href="#craniosynostosis.REF.goriely.2003.643">Goriely et al 2003</a>, <a class="bk_pop" href="#craniosynostosis.REF.choi.2008.10143">Choi et al 2008</a>, <a class="bk_pop" href="#craniosynostosis.REF.bochukova.2009.204">Bochukova et al 2009</a>, <a class="bk_pop" href="#craniosynostosis.REF.yoon.2009.e1000558">Yoon et al 2009</a>].</div></li><li class="half_rhythm"><div><i>FGFR3</i>-related <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> coronal synostosis is usually inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner with reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the parents.</div></li><li class="half_rhythm"><div>If a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk is 50%.</div></li><li class="half_rhythm"><div>When the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the DNA of either parent, the risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is low, but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Parental germline and <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> in Crouzon syndrome has also been reported [<a class="bk_pop" href="#craniosynostosis.REF.goriely.2010.2067">Goriely et al 2010</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Affected individuals have a 50% chance of passing the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to each child.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents.</div></li><li class="half_rhythm"><div>If a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</div></li></ul></div><div id="craniosynostosis.Related_Genetic_Counsel"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#craniosynostosis.Evaluation_of_Relatives">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p>Each syndrome is usually consistent within an individual family; for example, if a parent has the clinical findings of Pfeiffer syndrome, he or she has a 50% chance of having a child with Pfeiffer syndrome rather than Crouzon, Jackson-Weiss, or Apert syndrome. Nonetheless, rare examples in which the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in a given family has varied have been reported: some family members had findings suggestive of Pfeiffer syndrome, whereas others had findings suggestive of Jackson-Weiss or Crouzon syndromes [<a class="bk_pop" href="#craniosynostosis.REF.meyers.1996.491">Meyers et al 1996</a>, <a class="bk_pop" href="#craniosynostosis.REF.steinberger.1996.81">Steinberger et al 1996</a>, <a class="bk_pop" href="#craniosynostosis.REF.hollway.1997.251">Hollway et al 1997</a>, <a class="bk_pop" href="#craniosynostosis.REF.steinberger.1997.420">Steinberger et al 1997</a>].</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></b>. When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has clinical evidence of the disorder and/or the pathogenic variant, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="craniosynostosis.Prenatal_Testing_and_Pr"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>High-risk pregnancies.</b> Once the pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member has been identified, prenatal testing for a pregnancy at 50% risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>Low-risk pregnancies.</b> In a pregnancy not previously identified to be at risk for craniosynostosis in which an abnormal skull shape is detected on prenatal ultrasound examination, prenatal testing is more difficult. While testing for pathogenic variants in <i>FGFR1</i>, <i>FGFR2</i>, or <i>FGFR3</i> is possible, the yield is likely to be low. Furthermore, identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of these genes would not clarify the prognosis, which is determined by clinical findings (e.g., the prognosis for cloverleaf skull is generally poor regardless of the molecular defect or nature of hand and foot findings).</p><p>Prenatal diagnosis of various craniosynostosis syndromes may be possible if physical findings including abnormal biparietal diameter and ventriculomegaly are apparent on prenatal imaging [<a class="bk_pop" href="#craniosynostosis.REF.chen.2010.129">Chen et al 2010</a>, <a class="bk_pop" href="#craniosynostosis.REF.weber.2010.51">Weber et al 2010</a>].</p><p>Three-dimensional ultrasound examination, three-dimensional CT scan, or MRI has proven useful in some cases to further delineate suspicious ultrasound findings and assess for underlying brain abnormalities [<a class="bk_pop" href="#craniosynostosis.REF.benacerraf.2000.391">Benacerraf et al 2000</a>, <a class="bk_pop" href="#craniosynostosis.REF.mahieucaputo.2001.10">Mahieu-Caputo et al 2001</a>, <a class="bk_pop" href="#craniosynostosis.REF.hansen.2004.127">Hansen et al 2004</a>, <a class="bk_pop" href="#craniosynostosis.REF.itoh.2006.168">Itoh et al 2006</a>]. Prenatal MRI is often used to accurately diagnose suspected craniosynostosis syndromes such as Pfeiffer or Apert syndromes. Findings detectable by MRI may include agenesis of the corpus callosum, hydrocephalus causing increased biparietal diameter, or cloverleaf skull [<a class="bk_pop" href="#craniosynostosis.REF.itoh.2006.168">Itoh et al 2006</a>, <a class="bk_pop" href="#craniosynostosis.REF.quinterorivera.2006.966">Quintero-Rivera et al 2006</a>, <a class="bk_pop" href="#craniosynostosis.REF.weber.2010.51">Weber et al 2010</a>].</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="craniosynostosis.Resources"><h2 id="_craniosynostosis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Children's Craniofacial Association (CCA)</b></div><div>13140 Coit Road</div><div>Suite 517</div><div>Dallas TX 75240</div><div><b>Phone:</b> 800-535-3643 (toll-free)</div><div><b>Email:</b> contactCCA@ccakids.com</div><div><a href="https://ccakids.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ccakids.org</a></div></li><li class="half_rhythm"><div><b>Cleft Palate Foundation (CPF)</b></div><div>1504 East Franklin Street</div><div>Suite 102</div><div>Chapel Hill NC 27514-2820</div><div><b>Phone:</b> 800-242-5338 (toll-free); 919-933-9044</div><div><b>Fax:</b> 919-933-9604</div><div><b>Email:</b> info@cleftline.org</div><div><a href="http://www.cleftline.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cleftline.org</a></div></li><li class="half_rhythm"><div><b>Face Equality International</b></div><div>United Kingdom</div><div><b>Email:</b> info@faceequalityinternational.org</div><div><a href="https://faceequalityinternational.org/thealliance/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.faceequalityinternational.org</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Apert%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Apert syndrome</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Craniosynostosis-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Craniosynostosis Information Page</a></div></li></ul></div><div id="craniosynostosis.Molecular_Genetics"><h2 id="_craniosynostosis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="craniosynostosis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>FGFR-Related Craniosynostosis Syndromes: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1455/table/craniosynostosis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__craniosynostosis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_craniosynostosis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_craniosynostosis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_craniosynostosis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_craniosynostosis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_craniosynostosis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_craniosynostosis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2260" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FGFR1</i></a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2260" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8p11<wbr style="display:inline-block"></wbr>​.23</a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P11362" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Fibroblast growth factor receptor 1</a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FGFR1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR1 database</a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FGFR1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR1</a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FGFR1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR1</a></td></tr><tr><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2263" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FGFR2</i></a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2263" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q26<wbr style="display:inline-block"></wbr>​.13</a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P21802" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Fibroblast growth factor receptor 2</a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FGFR2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR2 @ LOVD</a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FGFR2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR2</a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FGFR2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR2</a></td></tr><tr><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2261" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FGFR3</i></a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2261" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">4p16<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P22607" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Fibroblast growth factor receptor 3</a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FGFR3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR3 @ LOVD</a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FGFR3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR3</a></td><td headers="hd_b_craniosynostosis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FGFR3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="craniosynostosis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="craniosynostosis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for FGFR-Related Craniosynostosis Syndromes (<a href="/omim/101200,101600,123150,123500,123790,134934,136350,176943,602849,612247" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1455/table/craniosynostosis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__craniosynostosis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/101200" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">101200</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">APERT SYNDROME</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/101600" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">101600</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PFEIFFER SYNDROME</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/123150" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">123150</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">JACKSON-WEISS SYNDROME; JWS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/123500" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">123500</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CROUZON SYNDROME</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/123790" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">123790</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/134934" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">134934</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/136350" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">136350</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBROBLAST GROWTH FACTOR RECEPTOR 1; FGFR1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/176943" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">176943</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBROBLAST GROWTH FACTOR RECEPTOR 2; FGFR2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602849" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602849</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MUENKE SYNDROME; MNKES</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612247" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612247</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS; CAN</td></tr></tbody></table></div></div><div id="craniosynostosis.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The fibroblast growth factors (FGFs) are a family of at least 22 known signaling molecules that function to regulate cell proliferation, differentiation, and migration through a variety of complex pathways [<a class="bk_pop" href="#craniosynostosis.REF.wilkie.1997.1647">Wilkie 1997</a>, <a class="bk_pop" href="#craniosynostosis.REF.coumoul.2003.286">Coumoul &#x00026; Deng 2003</a>]. They are important in angiogenesis, wound healing, limb development, mesoderm induction and patterning neuronal differentiation, and malignant transformation. They act through the fibroblast growth factor receptors (FGFRs), a family of four tyrosine kinase receptors that bind the FGFs in a nonspecific manner (any FGF can bind to any FGFR).</p><p>The FGFRs share the general structure of a split cytoplasmic tyrosine kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, a transmembrane domain, and an extracellular domain that contains three immunoglobulin (Ig)-like domains. Ligand binding occurs at the second and third Ig-like domains. After binding an FGF, an FGFR dimerizes with another FGFR through a series of cysteine residues in these Ig-like domains. Dimerization promotes activation of the tyrosine kinase, which initiates a complex cascade of intracellular signals including activation of Runx2, a key <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> in osteoblast differentiation [<a class="bk_pop" href="#craniosynostosis.REF.baroni.2005.524">Baroni et al 2005</a>, <a class="bk_pop" href="#craniosynostosis.REF.kim.2006.1166">Kim et al 2006</a>]. Both ligand binding and dimerization are nonspecific, with any type of FGFR binding to any FGF and then dimerizing with any FGFR.</p><p>The FGF/FGFR system achieves its specificity through temporal and spatial variations in expression patterns. Additional diversity is created by alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of exons of the <i>FGFRs</i>, exemplified by <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 7 of <i>FGFR2</i> [<a class="bk_pop" href="#craniosynostosis.REF.ornitz.2005.205">Ornitz 2005</a>]. A p.Cys278Phe <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR2</i> decreases protein glycosylation while increasing degradation, demonstrating that FGFR2 localization and autoactivation is glycosylation dependent [<a class="bk_pop" href="#craniosynostosis.REF.hatch.2006.27292">Hatch et al 2006</a>].</p><p>Although pathogenic variants in <i>FGFR1</i>, <i>FGFR2</i>, and <i>FGFR3</i> have been associated with a variety of clinical phenotypes (and, in those with craniosynostosis, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sutures) [<a class="bk_pop" href="#craniosynostosis.REF.wilkie.2010.e391">Wilkie et al 2010</a>], they have not been associated with nonsynostotic plagiocephaly [<a class="bk_pop" href="#craniosynostosis.REF.dhamcharee.2008.290">Dhamcharee &#x00026; Boles 2008</a>]. To date, no evidence linking <i>FGFR4</i> to craniofacial or skeletal disorders exists [<a class="bk_pop" href="#craniosynostosis.REF.gaudenz.1998.76">Gaudenz et al 1998</a>].</p><p>Interestingly, the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in either <i>FGFR1</i>, <i>FGFR2</i>, or <i>FGFR3</i> results in different clinical craniosynostosis syndromes, thus implicating a common pathogenic mechanism with FGFR gain of function in Pfeiffer, Apert, Muenke, and Beare-Stevenson syndromes [<a class="bk_pop" href="#craniosynostosis.REF.wilkie.2001.122">Wilkie et al 2001</a>]. FGF9 binding is enhanced in the <i>FGFR1</i> Pfeiffer-related variant p.Pro252Arg and the <i>FGFR3</i> Muenke-related variant p.Pro250Arg; thus, FGF9 may be a potential pathophysiologic ligand for mutated FGFRs in mediating craniosynostosis [<a class="bk_pop" href="#craniosynostosis.REF.ibrahimi.2004.69">Ibrahimi et al 2004</a>]. Differences in the primary sequence among FGFRs result in varying effects on ligand binding specificity [<a class="bk_pop" href="#craniosynostosis.REF.ibrahimi.2004.69">Ibrahimi et al 2004</a>].</p><p>The normal function of the FGFRs appears to be to restrain limb growth, as <i>FGFR3</i> knockout mice have elongated tails and hindlimbs [<a class="bk_pop" href="#craniosynostosis.REF.colvin.1996.390">Colvin et al 1996</a>, <a class="bk_pop" href="#craniosynostosis.REF.deng.1996.911">Deng et al 1996</a>]. This phenomenon suggests that <i>FGFR</i> pathogenic variants are hypermorphic, causing the <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a> to perform its normal function excessively. The exact mechanism of the hypermorphic effect is different for different types of pathogenic variants that have been reported in the <i>FGFR</i>-related craniosynostosis syndromes [<a class="bk_pop" href="#craniosynostosis.REF.wilkie.1997.1647">Wilkie 1997</a>].</p><p>It appears that the diseases caused by mutation of <i>FGFR2</i> in these clinically distinct syndromes may be points along a continuum of a phenotypic spectrum. Evidence to support this concept comes from reports of clinically unique phenotypes caused by <i>FGFR2</i> pathogenic variants. An example is the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of the family reported by <a class="bk_pop" href="#craniosynostosis.REF.steinberger.1996.81">Steinberger et al [1996]</a> with an <i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> previously associated with Crouzon syndrome but not consistent with any of the <i>FGFR2</i>-related craniosynostosis syndromes (i.e., Apert, Crouzon, Pfeiffer, and Jackson-Weiss). Affected family members lacked the broad and medially deviated thumbs of Pfeiffer syndrome. Only one of nine had broad great toes, but they were not medially deviated as one would expect with Jackson-Weiss syndrome. In addition, significant midfacial hypoplasia and ocular proptosis were not present, as would be expected with Crouzon syndrome.</p><div id="craniosynostosis.FGFR1"><h4><i>FGFR1</i></h4><p><b>Gene structure.</b>
<i>FGFR1</i> has a <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> size of approximately 58 kb. Several <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> splice variants produce seven <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>. Isoform 1 contains 18 total exons (17 coding exons) and has the largest mRNA product. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1455/#craniosynostosis.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> A single common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, p.Pro252Arg, in the linker region between the second and third Ig-like domains of <i>FGFR1</i> has been associated in five unrelated families with a relatively mild form of Pfeiffer syndrome type 1. <i>FGFR1</i> pathogenic variants have also been associated with Jackson-Weiss syndrome, osteoglophonic dysplasia, and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a href="/books/n/gene/kms/">Kallmann syndrome</a>. See <a href="/books/NBK1455/#craniosynostosis.molgen.TA">Table A</a>.</p><div id="craniosynostosis.T.selected_fgfr1_pathog" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>FGFR1</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr1_pathog/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__craniosynostosis.T.selected_fgfr1_pathog_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_craniosynostosis.T.selected_fgfr1_pathog_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_craniosynostosis.T.selected_fgfr1_pathog_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_craniosynostosis.T.selected_fgfr1_pathog_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr1_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.755C&#x0003e;G</td><td headers="hd_h_craniosynostosis.T.selected_fgfr1_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro252Arg</td><td headers="hd_h_craniosynostosis.T.selected_fgfr1_pathog_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nucleotide/105990521" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_023110<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/105990522" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_075598<wbr style="display:inline-block"></wbr>​.2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Basic fibroblast growth factor receptor 1 (FGFR1) has three extracellular Ig-like domains (only two of which are active), a transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, and a split tyrosine kinase intracellular domain. The Ig-like domains function in promiscuous ligand binding: any FGFR binds any FGF. With ligand binding, two FGFRs dimerize and activate the tyrosine kinase, initiating an intracellular cascade. Basic FGFR1 and FGFR2 <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> is found during embryogenesis in cartilage and bone precursors that will form the craniofacial and apical skeleton [<a class="bk_pop" href="#craniosynostosis.REF.muenke.1995.308">Muenke &#x00026; Schell 1995</a>]. In the apical skeleton, basic FGFR1 is expressed throughout the entire developing limb bud, whereas FGFR2 is primarily expressed in the outer ectodermal layer.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> No functional studies have been done on the <i>FGFR1</i> receptor variant p.Pro252Arg, but studies have been done on the analogous pathogenic variants seen in both <i>FGFR2</i> and <i>FGFR3</i>. Like the pathogenic variants seen in <i>FGFR2</i> and <i>FGFR3</i>, the <i>FGFR1</i> variant is dominant, so that the altered protein's effect is seen even in the presence of the normal second <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. Based on a number of studies on fibroblasts and animal models containing <i>FGFR</i> pathogenic variants, the effect appears to be one of excess activity; that is, the mutated receptors work better than the wild type. The p.Pro252Arg <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> occurs in the region between the second and third Ig-like loops, a site that is thought to be important in ligand binding. The substitution of the bulkier residue is thought to change the configuration of the site, thereby altering ligand binding. The increased affinity of the receptor for ligand causes excessive activity, which may then promote excessive receptor down-regulation (summarized in <a class="bk_pop" href="#craniosynostosis.REF.wilkie.2005.187">Wilkie [2005]</a>).</p></div><div id="craniosynostosis.FGFR2"><h4><i>FGFR2</i></h4><p><b>Gene structure.</b>
<i>FGFR2</i> contains approximately 120 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA with 18 total exons (17 coding exons). Alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> produces two <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>, where isoform 2 is one amino acid longer than isoform 1. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1455/#craniosynostosis.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Most <i>FGFR2</i> pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, although small insertions, deletions, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants have also been reported. No <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> or frameshift variants have been reported [<a class="bk_pop" href="#craniosynostosis.REF.wilkie.1997.1647">Wilkie 1997</a>]. Pathogenic variants in <i>FGFR2</i> have been associated with a variety of phenotypes including Apert, Crouzon, Pfeiffer, Jackson-Weiss, and Beare-Stevenson [<a class="bk_pop" href="#craniosynostosis.REF.przylepa.1996.492">Przylepa et al 1996</a>] syndromes. In addition, a novel <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> variant was found in a family in which the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, who displayed intrauterine constraint, had nonsyndromic unicoronal synostosis and other family members had only mild facial asymmetry without synostosis; this represents an example of interaction of environment and a genetic predisposition to cause craniosynostosis. See <a href="/books/NBK1455/#craniosynostosis.molgen.TA">Table A</a>.</p><p>Two common pathogenic variants account for 98% of Apert syndrome: p.Pro253Arg and p.Ser252Trp [<a class="bk_pop" href="#craniosynostosis.REF.ferreira.1999.426">Ferreira et al 1999</a>]. These variants occur in the identical location as the <i>FGFR1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in Pfeiffer syndrome and the <i>FGFR3</i> pathogenic variant in Muenke syndrome. This is the linker region between Ig-like loops II and III, the area thought to be critical in ligand binding; the replacement of a proline for a bulkier arginine may alter the orientation of the IgII and IgIII loops [<a class="bk_pop" href="#craniosynostosis.REF.wilkie.1997.1647">Wilkie 1997</a>]. The p.Ser252Trp variant is more common than the p.Pro253Arg variant, seen in 71% and 26% of individuals with Apert syndrome, respectively. Both variants augment receptor binding affinity; however, indiscriminate increased affinity of fibroblast growth factor receptor 2 (FGFR2) for any FGF is seen in p.Pro253Arg variants, whereas p.Ser252Trp variants convey a selective FGFR2 affinity for a limited subset of FGFs [<a class="bk_pop" href="#craniosynostosis.REF.ferreira.1999.426">Ferreira et al 1999</a>].</p><p>Rare unique variants involving Alu element <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> insertions have provided evidence that syndactyly in Apert syndrome is caused by signaling through keratinocyte growth factor receptors (KGFRs) [<a class="bk_pop" href="#craniosynostosis.REF.oldridge.1999.446">Oldridge et al 1999</a>].</p><p>Six <i>FGFR2</i> pathogenic variants have been identified in individuals with Jackson-Weiss syndrome [<a class="bk_pop" href="#craniosynostosis.REF.heike.2001.315">Heike et al 2001</a>]. Variants seen in individuals with Crouzon, Pfeiffer, and Jackson-Weiss syndromes occur in and around the B <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> of the third Ig-like <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> in FGFR2. The exon is subjected to alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>; it is included in the bone <i>FGFR2</i> isoform that is expressed in the cranial sutures and limbs, and is spliced out in making the KGFR. Pathogenic variants in and around the splice sites cause aberrant splicing [<a class="bk_pop" href="#craniosynostosis.REF.meyers.1996.491">Meyers et al 1996</a>]. Other variants cause a loss or gain of a cysteine residue, while others alter splice sites [<a class="bk_pop" href="#craniosynostosis.REF.wilkie.1997.1647">Wilkie 1997</a>]. Identical variants have been seen in individuals with Crouzon, Pfeiffer, and Jackson-Weiss syndromes [<a class="bk_pop" href="#craniosynostosis.REF.hollway.1997.251">Hollway et al 1997</a>, <a class="bk_pop" href="#craniosynostosis.REF.oldridge.1997.137">Oldridge et al 1997</a>], suggesting that unlinked modifier genes or epigenetic factors play a role in determining the final <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. A study of individuals with Crouzon and Pfeiffer syndromes found that 60% of pathogenic variants are caused by two mutational hot spots at the critical cysteine residues 278 and 342 [<a class="bk_pop" href="#craniosynostosis.REF.kress.2000.134">Kress et al 2000</a>]. Pathogenic variants in residues 372 and 375 were identified in individuals with Beare-Stevenson syndrome [<a class="bk_pop" href="#craniosynostosis.REF.fonseca.2008.658">Fonseca et al 2008</a>].</p><p>It is noteworthy that the <i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> appears to arise exclusively from the male <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> [<a class="bk_pop" href="#craniosynostosis.REF.moloney.1996.48">Moloney et al 1996</a>]. The pathogenic variant may convey an advantage in sperm, as the FGF/FGFR pathway is known to be important in maintaining and initiating spermatogenesis [<a class="bk_pop" href="#craniosynostosis.REF.van_disselemiliani.1996.647">Van Dissel-Emiliani et al 1996</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> mutation rate is high, with 11 of 21 cases of Crouzon syndrome and Pfeiffer syndrome found to arise from <i>de novo</i>
<i>FGFR2</i> pathogenic variants [<a class="bk_pop" href="#craniosynostosis.REF.kress.2000.134">Kress et al 2000</a>].</p><p>A mouse model of a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>Fgfr2c</i> orthologous to the human <i>FGFR2</i> pathogenic variant (p.Cys342Tyr) in Crouzon and Pfeiffer syndromes was shown to recapitulate the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of these disorders. Specific features seen in heterozygotes included shortened face, protruding eyes, and premature fusion of cranial sutures, while homozygotes displayed multiple joint fusions, cleft palate, and defects of the trachea and lung, and died shortly after birth. The study suggests that the long-term aspects of the mutated phenotype, including craniosynostosis, are related to the FGFR2 regulation of the osteoblast lineage [<a class="bk_pop" href="#craniosynostosis.REF.eswarakumar.2004.12555">Eswarakumar et al 2004</a>].</p><div id="craniosynostosis.T.selected_fgfr2_pathog" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Selected <i>FGFR2</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr2_pathog/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__craniosynostosis.T.selected_fgfr2_pathog_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.755C&#x0003e;T</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser252Leu</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_3" rowspan="16" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nucleotide/189083823" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000141<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/221316639" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000132<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.755C&#x0003e;G</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser252Trp</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.758C&#x0003e;G</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro253Arg</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.833G&#x0003e;T</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys278Phe</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.866A&#x0003e;C</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln289Pro</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.870G&#x0003e;T</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp290Cys</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.870G&#x0003e;C</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp290Cys</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.868T&#x0003e;G</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp290Gly</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.868T&#x0003e;G</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp290Arg</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1019A&#x0003e;G</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr340Cys</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1018T&#x0003e;C</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr340His</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1024T&#x0003e;C</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys342Arg</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1025G&#x0003e;A</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys342Tyr</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1031C&#x0003e;G</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala344Gly</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1052C&#x0003e;G</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser351Cys</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1576A&#x0003e;G</td><td headers="hd_h_craniosynostosis.T.selected_fgfr2_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys526Glu</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Basic FGFR1 has three extracellular Ig-like domains, a transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, and a split tyrosine kinase intracellular domain. The Ig-like domains function in promiscuous ligand binding: any FGFR binds any FGF. With ligand binding, two FGFRs dimerize and activate the tyrosine kinase, initiating an intracellular cascade. Basic <i>FGFR1</i> and <i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> is found during embryogenesis in cartilage and bone precursors that will form the craniofacial and apical skeleton [<a class="bk_pop" href="#craniosynostosis.REF.yin.2008.631">Yin et al 2008</a>]. In the apical skeleton, basic FGFR1 is expressed throughout the entire developing limb bud, while FGFR2 is primarily expressed in the outer ectodermal layer.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Like the pathogenic variants seen in <i>FGFR1</i> and <i>FGFR3</i>, <i>FGFR2</i> pathogenic variants are dominant, so that the effect of the altered protein is seen even in the presence of the normal second <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. Based on a number of studies on fibroblasts and animal models containing <i>FGFR</i> pathogenic variants, the effect seems to be one of excess activity; i.e., the mutated receptors work better than the wild type receptors [<a class="bk_pop" href="#craniosynostosis.REF.wilkie.1997.1647">Wilkie 1997</a>]. For example, one study suggested that variants causing Apert syndrome increase ligand affinity [<a class="bk_pop" href="#craniosynostosis.REF.anderson.1998.1475">Anderson et al 1998</a>] .The increased affinity of the receptor for the ligand causes excessive activity, which may then promote excessive receptor down-regulation (summarized in <a class="bk_pop" href="#craniosynostosis.REF.wilkie.2005.187">Wilkie [2005]</a>).</p><p>Mutation of exons IIIa and IIIc, the exons in <i>FGFR2</i> that are most commonly associated with Pfeiffer syndrome, frequently involves cysteine codons [<a class="bk_pop" href="#craniosynostosis.REF.cornejoroldan.1999.425">Cornejo-Roldan et al 1999</a>]. The loss or gain of the cysteine residues around the IgIII loop, as is commonly seen in Crouzon syndrome, may alter the configuration of the IgIII loop (cysteine-cysteine disulfide bonding is thought to stabilize the IgIII loop). A free unpaired cysteine may enable ligand-free dimerization and activation of the receptor. Similarly, other pathogenic variants that alter splice sites may alter ligand binding affinity or allow for ligand-free activation [<a class="bk_pop" href="#craniosynostosis.REF.wilkie.2005.187">Wilkie 2005</a>].</p></div><div id="craniosynostosis.FGFR3"><h4><i>FGFR3</i></h4><p><b>Gene structure.</b>
<i>FGFR3</i> has a <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> size of approximately 15 kb. There are two <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> splice variants, of which the full nature is unknown. Isoform 1 contains 17 exons and has the largest mRNA product. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1455/#craniosynostosis.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Pathogenic variants in <i>FGFR3</i> cause <a href="/books/n/gene/achondroplasia/">achondroplasia</a>, <a href="/books/n/gene/hypochondroplasia/">hypochondroplasia</a>, and <a href="/books/n/gene/td/">thanatophoric dysplasia</a>. An alanine-to-glutamic acid change at amino acid 391 (p.Ala391Glu) was identified in individuals with Crouzon syndrome with acanthosis nigricans (AN) [<a class="bk_pop" href="#craniosynostosis.REF.mulliken.1999.1603">Mulliken et al 1999</a>]. In addition, a single variant, p.Pro250Arg, was identified in a series of individuals and families with craniosynostosis (including some who had been previously diagnosed as having Pfeiffer, Jackson-Weiss, and Saethre-Chotzen syndromes) as well as in the original family with Adelaide-type craniosynostosis (now called Muenke syndrome). A p.Pro250Arg <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR3</i> was reported in an individual with a mild presentation of Beare-Stevenson syndrome and epidermal hyperplasia [<a class="bk_pop" href="#craniosynostosis.REF.roscioli.2001.187">Roscioli et al 2001</a>]. The same variant had been described in <i>FGFR2</i> (Apert syndrome) and <i>FGFR1</i> (Pfeiffer syndrome) [<a class="bk_pop" href="#craniosynostosis.REF.bellus.1996.174">Bellus et al 1996</a>, <a class="bk_pop" href="#craniosynostosis.REF.muenke.1997.555">Muenke et al 1997</a>]. See <a href="/books/NBK1455/#craniosynostosis.molgen.TA">Table A</a>.</p><div id="craniosynostosis.T.selected_fgfr3_pathog" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Selected <i>FGFR3</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1455/table/craniosynostosis.T.selected_fgfr3_pathog/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__craniosynostosis.T.selected_fgfr3_pathog_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.749C&#x0003e;G</td><td headers="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro250Arg</td><td headers="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000142" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000142<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/4503711" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000133<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1138G&#x0003e;A</td><td headers="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly380Arg</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1138G&#x0003e;C</td><td headers="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly380Arg&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1172C&#x0003e;A</td><td headers="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala391Glu</td></tr><tr><td headers="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1862G&#x0003e;A</td><td headers="hd_h_craniosynostosis.T.selected_fgfr3_pathog_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg621His</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="craniosynostosis.TF.6.1"><p class="no_margin">Associated with <a href="/books/n/gene/achondroplasia/">achondroplasia</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Fibroblast growth factor receptor 3 (<i>FGFR3</i>) <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> is found in highest amounts in the developing central nervous system, but is also present in resting cartilage and the skeletal precursors for all bones during the period of endochondral ossification, but not in hypertrophic cartilage. Normal FGFR3 product has two <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> as a result of alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of the third FGFR2-like loop; FGFR3 IIIa is found in the brain; FGFR3 IIIb is not.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Like the pathogenic variants seen in <i>FGFR1</i> and <i>FGFR2</i>, <i>FGFR3</i> pathogenic variants are dominant, so that the effect of the altered protein is seen even in the presence of the normal second <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. Based on a number of studies on fibroblasts and animal models containing <i>FGFR</i> pathogenic variants, the effect seems to be one of excess activity; i.e., the mutated receptors work better than the wild type (summarized in <a class="bk_pop" href="#craniosynostosis.REF.wilkie.2005.187">Wilkie [2005]</a>).</p><p>The p.Pro250Arg variant seen in Muenke syndrome occurs in the region between the second and third Ig-like loops, a site that is thought to be important in ligand binding. The substitution of the bulkier residue is thought to change the configuration of the site, thereby altering ligand binding. The increased affinity of the receptor for ligand causes excessive activity, which may then promote excessive receptor down-regulation [<a class="bk_pop" href="#craniosynostosis.REF.wilkie.2005.187">Wilkie 2005</a>].</p><p>No studies have been done on the p.Ala391Glu variant seen in Crouzon syndrome with AN, but much work has been done on the nearby p.Gly380Arg variant seen in achondroplasia, which demonstrates weak ligand-free activation. While it seems plausible that the p.Ala391Glu variant works in the same way, the widely different phenotypes produced by the two variants suggest that other mechanisms of action may be at work [<a class="bk_pop" href="#craniosynostosis.REF.chen.2005.1961">Chen &#x00026; Deng 2005</a>, <a class="bk_pop" href="#craniosynostosis.REF.wilkie.2005.187">Wilkie 2005</a>].</p></div></div></div><div id="craniosynostosis.References"><h2 id="_craniosynostosis_References_">References</h2><div id="craniosynostosis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.adachi.2006.633">Adachi M, Asakura Y, Matsuo M, Yamamoto T, Hanaki K, Arlt W. POR R457H is a global founder mutation causing Antley-Bixler syndrome with autosomal recessive trait. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:633–5.</span> [<a href="/pubmed/16470797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16470797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.akai.2006.108">Akai T, Yamamoto K, Iizuka H, Kawakami S, Yoshida J, Kakinuma H, Yaguchi Y, Ozawa T. Syndromic craniosynostosis with elbow joint contracture. <span><span class="ref-journal">Pediatr Neurosurg. </span>2006;<span class="ref-vol">42</span>:108–12.</span> [<a href="/pubmed/16465081" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16465081</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.anderson.1998.1475">Anderson J, Burns HD, Enriquez-Harris P, Wilkie AOM, Heath JK. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. <span><span class="ref-journal">Hum Mol Genet. </span>1998;<span class="ref-vol">7</span>:1475–83.</span> [<a href="/pubmed/9700203" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9700203</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.anderson.2006.166">Anderson PJ, Netherway DJ, Cox TC, Roscioli T, David DJ. Do Craniosynostosis syndrome phenotypes with both FGFR2 and TWIST mutations have a worse clinical outcome? <span><span class="ref-journal">J Craniofac Surg. </span>2006;<span class="ref-vol">17</span>:166–72.</span> [<a href="/pubmed/16432427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16432427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.barbosa.2009.260">Barbosa M, Almeida Mdo R, Reis-Lima M, Pinto-Basto J, dos Santos HG. Muenke syndrome with osteochondroma. <span><span class="ref-journal">Am J Med Genet. </span>2009;<span class="ref-vol">149A</span>:260–1.</span> [<a href="/pubmed/19097163" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19097163</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.baroni.2005.524">Baroni T, Carinci P, Lilli C, Bellucci C, Aisa MC, Scapoli L, Volinia S, Carinci F, Pezzetti F, Calvitti M, Farina A, Conte C, Bodo M. P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation. <span><span class="ref-journal">J Cell Physiol. </span>2005;<span class="ref-vol">202</span>:524–35.</span> [<a href="/pubmed/15389579" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15389579</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.bellus.1996.174">Bellus GA, Gaudenz K, Zackai EH, Clarke LA, Szabo J, Francomano CA, Muenke M. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. <span><span class="ref-journal">Nat Genet. </span>1996;<span class="ref-vol">14</span>:174–6.</span> [<a href="/pubmed/8841188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8841188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.benacerraf.2000.391">Benacerraf BR, Spiro R, Mitchell AG. Using three-dimensional ultrasound to detect craniosynostosis in a fetus with Pfeiffer syndrome. <span><span class="ref-journal">Ultrasound Obstet Gynecol. </span>2000;<span class="ref-vol">16</span>:391–4.</span> [<a href="/pubmed/11169319" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11169319</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.biesecker.1997.259">Biesecker LG. Strike three for GLI3. <span><span class="ref-journal">Nat Genet. </span>1997;<span class="ref-vol">17</span>:259–60.</span> [<a href="/pubmed/9354780" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9354780</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.binaghi.2000.856">Binaghi S, Gudinchet F, Rilliet B. Three-dimensional spiral CT of craniofacial malformations in children. <span><span class="ref-journal">Pediatr Radiol. </span>2000;<span class="ref-vol">30</span>:856–60.</span> [<a href="/pubmed/11149095" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11149095</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.bochukova.2009.204">Bochukova EG, Roscioli T, Hedges DJ, Taylor IB, Johnson D, David DJ, Deininger PL, Wilkie AO. Rare mutations of FGFR2 causing apert syndrome: identification of the first partial gene deletion, and an Alu element insertion from a new subfamily. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:204–11.</span> [<a href="/pubmed/18726952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18726952</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.bottero.1997.48">Bottero L, Cinalli G, Labrune P, Lajeunie E, Marchac D, Renier D. <span><span class="ref-journal">Ann Chir Plast Esthet. </span>1997;<span class="ref-vol">42</span>:48–55.</span> [Antley-Bixler syndrome. Description of two new cases and review of the literature. Prognostic and therapeutic aspects] [<a href="/pubmed/9768136" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9768136</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.chen.2008.165">Chen CP, Lin SP, Su YN, Chien SC, Tsai FJ, Wang W. Craniosynostosis and congenital tracheal anomalies in an infant with Pfeiffer syndrome carrying the W290C FGFR2 mutation. <span><span class="ref-journal">Genet Couns. </span>2008;<span class="ref-vol">19</span>:165–72.</span> [<a href="/pubmed/18618990" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18618990</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.chen.2010.129">Chen CP, Su YN, Hsu CY, Ling PY, Tsai FJ, Chern SR, Wu PC, Chen HE, Wang W. Second-trimester molecular prenatal diagnosis of sporadic Apert syndrome following sonographic findings of mild ventriculomegaly and clenched hands mimicking trisomy 18. <span><span class="ref-journal">Taiwan J Obstet Gynecol. </span>2010;<span class="ref-vol">49</span>:129–32.</span> [<a href="/pubmed/20466312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20466312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.chen.2005.1961">Chen L, Deng CX. Roles of FGF signaling in skeletal development and human genetic diseases. <span><span class="ref-journal">Front Biosci. </span>2005;<span class="ref-vol">10</span>:1961–76.</span> [<a href="/pubmed/15769677" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15769677</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.chinen.2006.1655">Chinen Y, Kaname T, Yanagi K, Saito N, Naritomi K, Ohta T. Opitz trigonocephaly C syndrome in a boy with a de novo balanced reciprocal translocation t(3;18)(q13.13;q12.1). <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:1655–7.</span> [<a href="/pubmed/16835930" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16835930</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.choi.2008.10143">Choi SK, Yoon SR, Calabrese P, Arnheim N. A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutations. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2008;<span class="ref-vol">105</span>:10143–8.</span> [<a href="/pmc/articles/PMC2474563/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2474563</span></a>] [<a href="/pubmed/18632557" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18632557</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.chun.2003.470">Chun K, Teebi AS, Azimi C, Steele L, Ray PN. Screening of patients with craniosynostosis: molecular strategy. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">120A</span>:470–3.</span> [<a href="/pubmed/12884424" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12884424</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.cohen.1996.503">Cohen MM Jr. A matter of reading English. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">63</span>:503–4.</span> [letter; comment] [<a href="/pubmed/8737661" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8737661</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.cohen.1993.300">Cohen MM Jr. Pfeiffer syndrome update, clinical subtypes, and guidelines for differential diagnosis. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">45</span>:300–7.</span> [<a href="/pubmed/8434615" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8434615</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.cohen.1993.758">Cohen MM Jr, Kreiborg S. Visceral anomalies in the Apert syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">45</span>:758–60.</span> [<a href="/pubmed/8456856" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8456856</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.colvin.1996.390">Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. <span><span class="ref-journal">Nat Genet. </span>1996;<span class="ref-vol">12</span>:390–7.</span> [<a href="/pubmed/8630492" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8630492</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.cornejoroldan.1999.425">Cornejo-Roldan LR, Roessler E, Muenke M. Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome. <span><span class="ref-journal">Hum Genet. </span>1999;<span class="ref-vol">104</span>:425–31.</span> [<a href="/pubmed/10394936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10394936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.coumoul.2003.286">Coumoul X, Deng CX. Roles of FGF receptors in mammalian development and congenital diseases. <span><span class="ref-journal">Birth Defects Res C Embryo Today. </span>2003;<span class="ref-vol">69</span>:286–304.</span> [<a href="/pubmed/14745970" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14745970</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.de_ravel.2005.503">de Ravel TJ, Taylor IB, Van Oostveldt AJ, Fryns JP, Wilkie AO. A further mutation of the FGFR2 tyrosine kinase domain in mild Crouzon syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2005;<span class="ref-vol">13</span>:503–5.</span> [<a href="/pubmed/15523492" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15523492</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.deng.1996.911">Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. <span><span class="ref-journal">Cell. </span>1996;<span class="ref-vol">84</span>:911–21.</span> [<a href="/pubmed/8601314" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8601314</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.dhamcharee.2008.290">Dhamcharee V, Boles RG. FGFR mutations and plagiocephaly. <span><span class="ref-journal">J Craniofac Surg. </span>2008;<span class="ref-vol">19</span>:290–1.</span> [<a href="/pubmed/18216705" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18216705</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.eswarakumar.2004.12555">Eswarakumar VP, Horowitz MC, Locklin R, Morriss-Kay GM, Lonai P. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2004;<span class="ref-vol">101</span>:12555–60.</span> [<a href="/pmc/articles/PMC515096/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC515096</span></a>] [<a href="/pubmed/15316116" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15316116</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.farrow.2006.537">Farrow EG, Davis SI, Mooney SD, Beighton P, Mascarenhas L, Gutierrez YR, Pitukcheewanont P, White KE. Extended mutational analyses of FGFR1 in osteoglophonic dysplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:537–9.</span> [<a href="/pubmed/16470795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16470795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.ferreira.1999.426">Ferreira JC, Carter SM, Bernstein PS, Jabs EW, Glickstein JS, Marion RW, Baergen RN, Gross SJ. Second-trimester molecular prenatal diagnosis of sporadic Apert syndrome following suspicious ultrasound findings. <span><span class="ref-journal">Ultrasound Obstet Gynecol. </span>1999;<span class="ref-vol">14</span>:426–30.</span> [<a href="/pubmed/10658283" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10658283</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.fonseca.2008.658">Fonseca R, Costa-Lima MA, Cosentino V, Orioli IM. Second case of Beare-Stevenson syndrome with an FGFR2 Ser372Cys mutation. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:658–60.</span> [<a href="/pubmed/18247426" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18247426</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.freeman.2008.223">Freeman L, Elakis G, Watson G, Mullan GL, Taylor PJ, Anderson P, Ogle R, Buckley MF, Roscioli T. Pfeiffer syndrome with neonatal death secondary to tracheal obstruction owing to the FGFR2 Glu565Ala mutation. <span><span class="ref-journal">Clin Dysmorphol. </span>2008;<span class="ref-vol">17</span>:223–4.</span> [<a href="/pubmed/18541976" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18541976</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.freitas.2006.142">Freitas EC, Nascimento SR, de Mello MP, Gil-da-Silva-Lopes VL. Q289P mutation in FGFR2 gene causes Saethre-Chotzen syndrome: some considerations about familial heterogeneity. <span><span class="ref-journal">Cleft Palate Craniofac J. </span>2006;<span class="ref-vol">43</span>:142–7.</span> [<a href="/pubmed/16526917" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16526917</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.gaudenz.1998.76">Gaudenz K, Roessler E, Vainikka S, Alitalo K, Muenke M. Analysis of patients with craniosynostosis syndromes for a pro246Arg mutation of FGFR4. <span><span class="ref-journal">Mol Genet Metab. </span>1998;<span class="ref-vol">64</span>:76–9.</span> [<a href="/pubmed/9682222" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9682222</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.glaser.2000.768">Glaser RL, Jiang W, Boyadjiev SA, Tran AK, Zachary AA, Van Maldergem L, Johnson D, Walsh S, Oldridge M, Wall SA, Wilkie AO, Jabs EW. Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">66</span>:768–77.</span> [<a href="/pmc/articles/PMC1288162/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288162</span></a>] [<a href="/pubmed/10712195" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10712195</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.gonzales.2005.179">Gonzales M, Heuertz S, Martinovic J, Delahaye S, Bazin A, Loget P, Pasquier L, Le Merrer M, Bonaventure J. Vertebral anomalies and cartilaginous tracheal sleeve in three patients with Pfeiffer syndrome carrying the S351C FGFR2 mutation. <span><span class="ref-journal">Clin Genet. </span>2005;<span class="ref-vol">68</span>:179–81.</span> [<a href="/pubmed/15996217" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15996217</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.goriely.2003.643">Goriely A, McVean GA, Rojmyr M, Ingemarsson B, Wilkie AO. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">301</span>:643–6.</span> [<a href="/pubmed/12893942" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12893942</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.goriely.2010.2067">Goriely A, Lord H, Lim J, Johnson D, Lester T, Firth HV, Wilkie AO. Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in "paternal age-effect" syndromes. <span><span class="ref-journal">Am J Med Genet. </span>2010;<span class="ref-vol">152A</span>:2067–73.</span> [<a href="/pmc/articles/PMC2988406/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2988406</span></a>] [<a href="/pubmed/20635358" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20635358</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.gripp.1998.714">Gripp KW, McDonald-McGinn DM, Gaudenz K, Whitaker LA, Bartlett SP, Glat PM, Cassileth LB, Mayro R, Zackai EH, Muenke M. Identification of a genetic cause for isolated unilateral coronal synostosis: a unique mutation in the fibroblast growth factor receptor 3. <span><span class="ref-journal">J Pediatr. </span>1998;<span class="ref-vol">132</span>:714–6.</span> [<a href="/pubmed/9580776" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9580776</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.grosso.2003.88">Grosso S, Farnetani MA, Berardi R, Bartalini G, Carpentieri M, Galluzzi P, Mostardini R, Morgese G, Balestri P. Medial temporal lobe dysgenesis in Muenke syndrome and hypochondroplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">120A</span>:88–91.</span> [<a href="/pubmed/12794698" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12794698</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.hackett.2006.207">Hackett A, Rowe L. FGFR1 Pfeiffer syndrome without craniosynostosis: an additional case report. <span><span class="ref-journal">Clin Dysmorphol. </span>2006;<span class="ref-vol">15</span>:207–10.</span> [<a href="/pubmed/16957473" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16957473</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.hansen.2004.127">Hansen WF, Rijhsinghani A, Grant S, Yankowitz J. Prenatal diagnosis of Apert syndrome. <span><span class="ref-journal">Fetal Diagn Ther. </span>2004;<span class="ref-vol">19</span>:127–30.</span> [<a href="/pubmed/14764955" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14764955</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.hatch.2006.27292">Hatch NE, Hudson M, Seto ML, Cunningham ML, Bothwell M. Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F. <span><span class="ref-journal">J Biol Chem. </span>2006;<span class="ref-vol">281</span>:27292–305.</span> [<a href="/pubmed/16844695" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16844695</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.heike.2001.315">Heike C, Seto M, Hing A, Palidin A, Hu FZ, Preston RA, Ehrlich GD, Cunningham M. Century of Jackson-Weiss syndrome: further definition of clinical and radiographic findings in "lost" descendants of the original kindred. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">100</span>:315–24.</span> [<a href="/pubmed/11343323" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11343323</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.hockstein.2004.1298">Hockstein NG, McDonald-McGinn D, Zackai E, Bartlett S, Huff DS, Jacobs IN. Tracheal anomalies in Pfeiffer syndrome. <span><span class="ref-journal">Arch Otolaryngol Head Neck Surg. </span>2004;<span class="ref-vol">130</span>:1298–302.</span> [<a href="/pubmed/15545585" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15545585</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.hollway.1997.251">Hollway GE, Suthers GK, Haan EA, Thompson E, David DJ, Gecz J, Mulley JC. Mutation detection in FGFR2 craniosynostosis syndromes. <span><span class="ref-journal">Hum Genet. </span>1997;<span class="ref-vol">99</span>:251–5.</span> [<a href="/pubmed/9048930" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9048930</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.honnebier.2008.919">Honnebier MB, Cabiling DS, Hetlinger M, McDonald-McGinn DM, Zackai EH, Bartlett SP. The natural history of patients treated for FGFR3-associated (Muenke-type) craniosynostosis. <span><span class="ref-journal">Plast Reconstr Surg. </span>2008;<span class="ref-vol">121</span>:919–31.</span> [<a href="/pubmed/18317141" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18317141</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.hunt.1996.127">Hunt CE, Puczynski MS. Does supine sleeping cause asymmetric heads? <span><span class="ref-journal">Pediatrics. </span>1996;<span class="ref-vol">98</span>:127–9.</span> [<a href="/pubmed/8668385" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8668385</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.ibrahimi.2004.69">Ibrahimi OA, Zhang F, Eliseenkova AV, Linhardt RJ, Mohammadi M. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. <span><span class="ref-journal">Hum Mol Genet. </span>2004;<span class="ref-vol">13</span>:69–78.</span> [<a href="/pubmed/14613973" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14613973</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.ignelzi.2003.751">Ignelzi MA Jr, Wang W, Young AT. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures. <span><span class="ref-journal">J Bone Miner Res. </span>2003;<span class="ref-vol">18</span>:751–9.</span> [<a href="/pubmed/12674336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12674336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.ito.2005.23">Ito S, Sekido K, Kanno H, Sato H, Tanaka M, Yamaguchi K, Yamamoto I. Phenotypic diversity in patients with craniosynostoses unrelated to Apert syndrome: the role of fibroblast growth factor receptor gene mutations. <span><span class="ref-journal">J Neurosurg. </span>2005;<span class="ref-vol">102</span>:23–30.</span> [<a href="/pubmed/16206730" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16206730</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.itoh.2006.168">Itoh S, Nojima M, Yoshida K. Usefulness of magnetic resonance imaging for accurate diagnosis of Pfeiffer syndrome type II in utero. <span><span class="ref-journal">Fetal Diagn Ther. </span>2006;<span class="ref-vol">21</span>:168–71.</span> [<a href="/pubmed/16490997" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16490997</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.jadico.2006.521">Jadico SK, Young DA, Huebner A, Edmond JC, Pollock AN, McDonald-McGinn DM, Li YJ, Zackai EH, Young TL. Ocular abnormalities in Apert syndrome: genotype/phenotype correlations with fibroblast growth factor receptor type 2 mutations. <span><span class="ref-journal">J AAPOS. </span>2006;<span class="ref-vol">10</span>:521–7.</span> [<a href="/pubmed/17189145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17189145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.jehee.2006.148">Jehee FS, Alonso LG, Cavalcanti DP, Kim C, Wall SA, Mulliken JB, Sun M, Jabs EW, Boyadjiev SA, Wilkie AO, Passos-Bueno MR. Mutational screening of FGFR1, CER1, and CDON in a large cohort of trigonocephalic patients. <span><span class="ref-journal">Cleft Palate Craniofac J. </span>2006;<span class="ref-vol">43</span>:148–51.</span> [<a href="/pubmed/16526918" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16526918</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.jenkins.2007.1162">Jenkins D, Seelow D, Jehee FS, Perlyn CA, Alonso LG, Bueno DF, Donnai D, Josifova D, Mathijssen IM, Morton JE, Orstavik KH, Sweeney E, Wall SA, Marsh JL, Nurnberg P, Passos-Bueno MR, Wilkie AO. RAB23 mutations in Carpenter syndrome imply an unexpected role for hedgehog signaling in cranial-suture development and obesity. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">80</span>:1162–70.</span> [<a href="/pmc/articles/PMC1867103/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1867103</span></a>] [<a href="/pubmed/17503333" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17503333</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.kan.2002.472">Kan SH, Elanko N, Johnson D, Cornejo-Roldan L, Cook J, Reich EW, Tomkins S, Verloes A, Twigg SR, Rannan-Eliya S, McDonald-McGinn DM, Zackai EH, Wall SA, Muenke M, Wilkie AO. Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:472–86.</span> [<a href="/pmc/articles/PMC384921/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC384921</span></a>] [<a href="/pubmed/11781872" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11781872</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.kanauchi.2003.302">Kanauchi Y, Muragaki Y, Ogino T, Takahara M, Tsuchida H, Ishigaki D. FGFR2 mutation in a patient with Apert syndrome associated with humeroradial synostosis. <span><span class="ref-journal">Congenit Anom (Kyoto). </span>2003;<span class="ref-vol">43</span>:302–5.</span> [<a href="/pubmed/15041782" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15041782</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.kane.1996.877">Kane AA, Mitchell LE, Craven KP, Marsh JL. Observations on a recent increase in plagiocephaly without synostosis. <span><span class="ref-journal">Pediatrics. </span>1996;<span class="ref-vol">97</span>:877–85.</span> [<a href="/pubmed/8657530" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8657530</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.kim.2006.1166">Kim BG, Kim HJ, Park HJ, Kim YJ, Yoon WJ, Lee SJ, Ryoo HM, Cho JY. Runx2 phosphorylation induced by fibroblast growth factor-2/protein kinase C pathways. <span><span class="ref-journal">Proteomics. </span>2006;<span class="ref-vol">6</span>:1166–74.</span> [<a href="/pubmed/16421932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16421932</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.klopocki.2011.70">Klopocki E, Lohan S, Brancati F, Koll R, Brehm A, Seemann P, Dathe K, Stricker S, Hecht J, Bosse K, Betz RC, Garaci FG, Dallapiccola B, Jain M, Muenke M, Ng VC, Chan W, Chan D, Mundlos S. Copy-number variations involving the IHH locus are associated with syndactyly and craniosynostosis. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">88</span>:70–5.</span> [<a href="/pmc/articles/PMC3014361/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3014361</span></a>] [<a href="/pubmed/21167467" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21167467</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.kress.2000.134">Kress W, Collmann H, Busse M, Halliger-Keller B, Mueller CR. Clustering of FGFR2 gene mutations in patients with Pfeiffer and Crouzon syndromes (FGFR2-associated craniosynostoses). <span><span class="ref-journal">Cytogenet Cell Genet. </span>2000;<span class="ref-vol">91</span>:134–7.</span> [<a href="/pubmed/11173845" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11173845</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.kress.2006.39">Kress W, Schropp C, Lieb G, Petersen B, Busse-Ratzka M, Kunz J, Reinhart E, Schafer WD, Sold J, Hoppe F, Pahnke J, Trusen A, Sorensen N, Krauss J, Collmann H. Saethre-Chotzen syndrome caused by TWIST 1 gene mutations: functional differentiation from Muenke coronal synostosis syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2006;<span class="ref-vol">14</span>:39–48.</span> [<a href="/pubmed/16251895" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16251895</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.lai.2008.73">Lai AH, Tan YM, Law HY, Yeow VK. A mutation in FGFR2 in a child with Pfeiffer syndrome and a sacral appendage. <span><span class="ref-journal">Clin Dysmorphol. </span>2008;<span class="ref-vol">17</span>:73–4.</span> [<a href="/pubmed/18049087" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18049087</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.lajeunie.2000.159">Lajeunie E, Bonaventure J, El Ghouzzi V, Catala M, Renier D. Monozygotic twins with Crouzon syndrome: concordance for craniosynostosis and discordance for thumb duplication. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">91</span>:159–60.</span> [<a href="/pubmed/10748419" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10748419</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.lajeunie.1999.443">Lajeunie E, Cameron R, El Ghouzzi V, de Parseval N, Journeau P, Gonzales M, Delezoide AL, Bonaventure J, Le Merrer M, Renier D. Clinical variability in patients with Apert's syndrome. <span><span class="ref-journal">J Neurosurg. </span>1999;<span class="ref-vol">90</span>:443–7.</span> [<a href="/pubmed/10067911" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10067911</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.lajeunie.2006.289">Lajeunie E, Heuertz S, El Ghouzzi V, Martinovic J, Renier D, Le Merrer M, Bonaventure J. Mutation screening in patients with syndromic craniosynostoses indicates that a limited number of recurrent FGFR2 mutations accounts for severe forms of Pfeiffer syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2006;<span class="ref-vol">14</span>:289–98.</span> [<a href="/pubmed/16418739" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16418739</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.lajeunie.1996.282">Lajeunie E, Le Merrer M, Bonaiti-Pellie C, Marchac D, Renier D. Genetic study of scaphocephaly. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">62</span>:282–5.</span> [<a href="/pubmed/8882788" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8882788</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.lapunzina.2005.61">Lapunzina P, Fernandez A, Sanchez Romero JM, Delicado A, Saenz de Pipaon M, Lopez Pajares I, Molano J. A novel insertion in the FGFR2 gene in a patient with Crouzon phenotype and sacrococcygeal tail. <span><span class="ref-journal">Birth Defects Res A Clin Mol Teratol. </span>2005;<span class="ref-vol">73</span>:61–4.</span> [<a href="/pubmed/15602758" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15602758</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.mahieucaputo.2001.10">Mahieu-Caputo D, Sonigo P, Amiel J, Simon I, Aubry MC, Lemerrer M, Delezoide AL, Gigarel N, Dommergues M, Dumez Y. Prenatal diagnosis of sporadic Apert syndrome: a sequential diagnostic approach combining three-dimensional computed tomography and molecular biology. <span><span class="ref-journal">Fetal Diagn Ther. </span>2001;<span class="ref-vol">16</span>:10–2.</span> [<a href="/pubmed/11125244" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11125244</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.marohnic.2006.35975">Marohnic CC, Panda SP, Martasek P, Masters BS. Diminished FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase. <span><span class="ref-journal">J Biol Chem. </span>2006;<span class="ref-vol">281</span>:35975–82.</span> [<a href="/pubmed/16998238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16998238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.matsumoto.2003.117">Matsumoto K, Nakanishi H, Kubo Y, Yokozeki M, Moriyama K. Advances in distraction techniques for craniofacial surgery. <span><span class="ref-journal">J Med Invest. </span>2003;<span class="ref-vol">50</span>:117–25.</span> [<a href="/pubmed/13678380" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13678380</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.mcgillivray.2005.656">McGillivray G, Savarirayan R, Cox TC, Stojkoski C, McNeil R, Bankier A, Bateman JF, Roscioli T, Gardner RJ, Lamande SR. Familial scaphocephaly syndrome caused by a novel mutation in the FGFR2 tyrosine kinase domain. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:656–62.</span> [<a href="/pmc/articles/PMC1736114/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1736114</span></a>] [<a href="/pubmed/16061565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16061565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.meyers.1996.491">Meyers GA, Day D, Goldberg R, Daentl DL, Przylepa KA, Abrams LJ, Graham JM Jr, Feingold M, Moeschler JB, Rawnsley E, Scott AF, Jabs EW. FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. <span><span class="ref-journal">Am J Hum Genet. </span>1996;<span class="ref-vol">58</span>:491–8.</span> [<a href="/pmc/articles/PMC1914562/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1914562</span></a>] [<a href="/pubmed/8644708" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8644708</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.moloney.1996.48">Moloney DM, Slaney SF, Oldridge M, Wall SA, Sahlin P, Stenman G, Wilkie AO. Exclusive paternal origin of new mutations in Apert syndrome. <span><span class="ref-journal">Nat Genet. </span>1996;<span class="ref-vol">13</span>:48–53.</span> [see comments] [<a href="/pubmed/8673103" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8673103</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.muenke.1995.308">Muenke M, Schell U. Fibroblast-growth-factor receptor mutations in human skeletal disorders. <span><span class="ref-journal">Trends Genet. </span>1995;<span class="ref-vol">11</span>:308–13.</span> [<a href="/pubmed/8585128" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8585128</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.muenke.1997.555">Muenke M, Gripp KW, McDonald-McGinn DM, Gaudenz K, Whitaker LA, Bartlett SP, Markowitz RI, Robin NH, Nwokoro N, Mulvihill JJ, Losken HW, Mulliken JB, Guttmacher AE, Wilroy RS, Clarke LA, Hollway G, Ades LC, Haan EA, Mulley JC, Cohen MM Jr, Bellus GA, Francomano CA, Moloney DM, Wall SA, Wilkie AO, et al.  A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>1997;<span class="ref-vol">60</span>:555–64.</span> [<a href="/pmc/articles/PMC1712518/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1712518</span></a>] [<a href="/pubmed/9042914" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9042914</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.mulliken.2004.1899">Mulliken JB, Gripp KW, Stolle CA, Steinberger D, Muller U. Molecular analysis of patients with synostotic frontal plagiocephaly (unilateral coronal synostosis). <span><span class="ref-journal">Plast Reconstr Surg. </span>2004;<span class="ref-vol">113</span>:1899–909.</span> [<a href="/pubmed/15253176" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15253176</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.mulliken.1999.1603">Mulliken JB, Steinberger D, Kunze S, Muller U. Molecular diagnosis of bilateral coronal synostosis. <span><span class="ref-journal">Plast Reconstr Surg. </span>1999;<span class="ref-vol">104</span>:1603–15.</span> [<a href="/pubmed/10541159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10541159</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.murdochkinch.1997.61">Murdoch-Kinch CA, Ward RE. Metacarpophalangeal analysis in Crouzon syndrome: additional evidence for phenotypic convergence with the acrocephalosyndactyly syndromes. <span><span class="ref-journal">Am J Med Genet. </span>1997;<span class="ref-vol">73</span>:61–6.</span> [<a href="/pubmed/9375924" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9375924</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.oldridge.1997.137">Oldridge M, Lunt PW, Zackai EH, McDonald-McGinn DM, Muenke M, Moloney DM, Twigg SR, Heath JK, Howard TD, Hoganson G, Gagnon DM, Jabs EW, Wilkie AO. Genotype-phenotype correlation for nucleotide substitutions in the IgII- IgIII linker of FGFR2. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:137–43.</span> [<a href="/pubmed/9002682" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9002682</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.oldridge.1999.446">Oldridge M, Zackai EH, McDonald-McGinn DM, Iseki S, Morriss-Kay GM, Twigg SR, Johnson D, Wall SA, Jiang W, Theda C, Jabs EW, Wilkie AO. De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:446–61.</span> [<a href="/pmc/articles/PMC1377754/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377754</span></a>] [<a href="/pubmed/9973282" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9973282</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.oliveira.2006.629">Oliveira NA, Alonso LG, Fanganiello RD, Passos-Bueno MR. Further evidence of association between mutations in FGFR2 and syndromic craniosynostosis with sacrococcygeal eversion. <span><span class="ref-journal">Birth Defects Res A Clin Mol Teratol. </span>2006;<span class="ref-vol">76</span>:629–33.</span> [<a href="/pubmed/16955501" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16955501</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.ornitz.2005.205">Ornitz DM. FGF signaling in the developing endochondral skeleton. <span><span class="ref-journal">Cytokine Growth Factor Rev. </span>2005;<span class="ref-vol">16</span>:205–13.</span> [<a href="/pmc/articles/PMC3083241/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3083241</span></a>] [<a href="/pubmed/15863035" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15863035</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.passosbueno.2008.107">Passos-Bueno MR, Serti Eacute AE, Jehee FS, Fanganiello R, Yeh E. Genetics of craniosynostosis: genes, syndromes, mutations and genotype-phenotype correlations. <span><span class="ref-journal">Front Oral Biol. </span>2008;<span class="ref-vol">12</span>:107–43.</span> [<a href="/pubmed/18391498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18391498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.posnick.2000.433">Posnick JC, Ruiz RL. The craniofacial dysostosis syndromes: current surgical thinking and future directions. <span><span class="ref-journal">Cleft Palate Craniofac J. </span>2000;<span class="ref-vol">37</span>:433.</span> [<a href="/pubmed/11034022" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11034022</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.przylepa.1996.492">Przylepa KA, Paznekas W, Zhang M, Golabi M, Bias W, Bamshad MJ, Carey JC, Hall BD, Stevenson R, Orlow S, Cohen MM Jr, Jabs EW. Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. <span><span class="ref-journal">Nat Genet. </span>1996;<span class="ref-vol">13</span>:492–4.</span> [<a href="/pubmed/8696350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8696350</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.quinterorivera.2006.966">Quintero-Rivera F, Robson CD, Reiss RE, Levine D, Benson C, Mulliken JB, Kimonis VE. Apert syndrome: what prenatal radiographic findings should prompt its consideration? <span><span class="ref-journal">Prenat Diagn. </span>2006;<span class="ref-vol">26</span>:966–72.</span> [<a href="/pubmed/16906598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16906598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.ranger.2010.427">Ranger A, Al-Hayek A, Matic D. Chiari type 1 malformation in an infant with type 2 Pfeiffer syndrome: further evidence of acquired pathogenesis. <span><span class="ref-journal">J Craniofac Surg. </span>2010;<span class="ref-vol">21</span>:427–31.</span> [<a href="/pubmed/20186072" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20186072</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.rannaneliya.2004.200">Rannan-Eliya SV, Taylor IB, De Heer IM, Van Den Ouweland AM, Wall SA, Wilkie AO. Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis. <span><span class="ref-journal">Hum Genet. </span>2004;<span class="ref-vol">115</span>:200–7.</span> [<a href="/pubmed/15241680" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15241680</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.renier.1996.66">Renier D, Arnaud E, Cinalli G, Sebag G, Zerah M, Marchac D. Prognosis for mental function in Apert's syndrome. <span><span class="ref-journal">J Neurosurg. </span>1996;<span class="ref-vol">85</span>:66–72.</span> [<a href="/pubmed/8683284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8683284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.renier.2000a.631">Renier D, El-Ghouzzi V, Bonaventure J, Le Merrer M, Lajeunie E. Fibroblast growth factor receptor 3 mutation in nonsyndromic coronal synostosis: clinical spectrum, prevalence, and surgical outcome. <span><span class="ref-journal">J Neurosurg. </span>2000a;<span class="ref-vol">92</span>:631–6.</span> [<a href="/pubmed/10761652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10761652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.renier.2000b.645">Renier D, Lajeunie E, Arnaud E, Marchac D. Management of craniosynostoses. <span><span class="ref-journal">Childs Nerv Syst. </span>2000b;<span class="ref-vol">16</span>:645–58.</span> [<a href="/pubmed/11151714" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11151714</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.robin.1996.184">Robin NH, Segel B, Carpenter G, Muenke M. Craniosynostosis, Philadelphia type: a new autosomal dominant syndrome with sagittal craniosynostosis and syndactyly of the fingers and toes. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">62</span>:184–91.</span> [<a href="/pubmed/8882401" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8882401</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.roscioli.2001.187">Roscioli T, Flanagan S, Mortimore RJ, Kumar P, Weedon D, Masel J, Lewandowski R, Hyland V, Glass IA. Premature calvarial synostosis and epidermal hyperplasia (Beare-Stevenson syndrome-like anomalies) resulting from a P250R missense mutation in the gene encoding fibroblast growth factor receptor 3. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">101</span>:187–94.</span> [<a href="/pubmed/11424131" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11424131</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.rossi.2003.269">Rossi M, Jones RL, Norbury G, Bloch-Zupan A, Winter RM. The appearance of the feet in Pfeiffer syndrome caused by FGFR1 P252R mutation. <span><span class="ref-journal">Clin Dysmorphol. </span>2003;<span class="ref-vol">12</span>:269–74.</span> [<a href="/pubmed/14564217" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14564217</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.rouzier.2008.696">Rouzier C, Soler C, Hofman P, Brennetot C, Bieth E, Pedeutour F. Ovarian dysgerminoma and Apert syndrome. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2008;<span class="ref-vol">50</span>:696–8.</span> [<a href="/pubmed/17243131" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17243131</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.saavedra.1996.147">Saavedra D, Richieri-Costa A, Guion-Almeida ML, Cohen MM Jr. Craniofrontonasal syndrome: study of 41 patients. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">61</span>:147–51.</span> [<a href="/pubmed/8669441" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8669441</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.schweitzer.2001.75">Schweitzer DN, Graham JM Jr, Lachman RS, Jabs EW, Okajima K, Przylepa KA, Shanske A, Chen K, Neidich JA, Wilcox WR. Subtle radiographic findings of achondroplasia in patients with Crouzon syndrome with acanthosis nigricans due to an Ala391Glu substitution in FGFR3. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">98</span>:75–91.</span> [<a href="/pubmed/11426459" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11426459</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.slaney.1996.923">Slaney SF, Oldridge M, Hurst JA, Moriss-Kay GM, Hall CM, Poole MD, Wilkie AO. Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>1996;<span class="ref-vol">58</span>:923–32.</span> [<a href="/pmc/articles/PMC1914616/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1914616</span></a>] [<a href="/pubmed/8651276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8651276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.steinberger.1997.420">Steinberger D, Collmann H, Schmalenberger B, Muller U. A novel mutation (a886g) in exon 5 of FGFR2 in members of a family with Crouzon phenotype and plagiocephaly. <span><span class="ref-journal">J Med Genet. </span>1997;<span class="ref-vol">34</span>:420–2.</span> [<a href="/pmc/articles/PMC1050952/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1050952</span></a>] [<a href="/pubmed/9152842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9152842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.steinberger.1996.81">Steinberger D, Reinhartz T, Unsold R, Muller U. FGFR2 mutation in clinically nonclassifiable autosomal dominant craniosynostosis with pronounced phenotypic variation. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">66</span>:81–6.</span> [<a href="/pubmed/8957519" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8957519</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.stevens.2006.187">Stevens CA, Roeder ER. Ser351Cys mutation in the fibroblast growth factor receptor 2 gene results in severe Pfeiffer syndrome. <span><span class="ref-journal">Clin Dysmorphol. </span>2006;<span class="ref-vol">15</span>:187–8.</span> [<a href="/pubmed/16760743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16760743</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.stoler.2009.1375">Stoler JM, Rosen H, Desai U, Mulliken JB, Meara JG, Rogers GF. Cleft palate in Pfeiffer syndrome. <span><span class="ref-journal">J Craniofac Surg. </span>2009;<span class="ref-vol">20</span>:1375–7.</span> [<a href="/pubmed/19816260" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19816260</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.tartaglia.1999.389">Tartaglia M, Bordoni V, Velardi F, Basile RT, Saulle E, Tenconi R, Di Rocco C, Battaglia PA. Fibroblast growth factor receptor mutational screening in newborns affected by metopic synostosis. <span><span class="ref-journal">Childs Nerv Syst. </span>1999;<span class="ref-vol">15</span>:389–93.</span> [<a href="/pubmed/10447608" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10447608</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.tholpady.2004.431">Tholpady SS, Abdelaal MM, Dufresne CR, Gampper TJ, Lin KY, Jane JA Sr, Morgan RF, Ogle RC. Aberrant bony vasculature associated with activating fibroblast growth factor receptor mutations accompanying Crouzon syndrome. <span><span class="ref-journal">J Craniofac Surg. </span>2004;<span class="ref-vol">15</span>:431–5.</span> [<a href="/pubmed/15111803" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15111803</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.thomas.2005.347">Thomas GP, Wilkie AO, Richards PG, Wall SA. FGFR3 P250R mutation increases the risk of reoperation in apparent 'nonsyndromic' coronal craniosynostosis. <span><span class="ref-journal">J Craniofac Surg. </span>2005;<span class="ref-vol">16</span>:347–52.</span> [<a href="/pubmed/15915095" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15915095</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.toydemir.2006.935">Toydemir RM, Brassington AE, Bayrak-Toydemir P, Krakowiak PA, Jorde LB, Whitby FG, Longo N, Viskochil DH, Carey JC, Bamshad MJ. A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">79</span>:935–41.</span> [<a href="/pmc/articles/PMC1698566/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1698566</span></a>] [<a href="/pubmed/17033969" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17033969</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.trarbach.2006.4006">Trarbach EB, Costa EM, Versiani B, de Castro M, Baptista MT, Garmes HM, de Mendonca BB, Latronico AC. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2006;<span class="ref-vol">91</span>:4006–12.</span> [<a href="/pubmed/16882753" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16882753</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.van_disselemiliani.1996.647">Van Dissel-Emiliani FM, De Boer-Brouwer M, De Rooij DG. Effect of fibroblast growth factor-2 on Sertoli cells and gonocytes in coculture during the perinatal period. <span><span class="ref-journal">Endocrinology. </span>1996;<span class="ref-vol">137</span>:647–54.</span> [<a href="/pubmed/8593814" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8593814</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.van_maldergem.2006.148">Van Maldergem L, Siitonen HA, Jalkh N, Chouery E, De Roy M, Delague V, Muenke M, Jabs EW, Cai J, Wang LL, Plon SE, Fourneau C, Kestila M, Gillerot Y, Megarbane A, Verloes A. Revisiting the craniosynostosis-radial ray hypoplasia association: Baller-Gerold syndrome caused by mutations in the RECQL4 gene. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:148–52.</span> [<a href="/pmc/articles/PMC2564634/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2564634</span></a>] [<a href="/pubmed/15964893" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15964893</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.villanueva.2010.51">Villanueva C, de Roux N. FGFR1 mutations in Kallmann syndrome. <span><span class="ref-journal">Front Horm Res. </span>2010;<span class="ref-vol">39</span>:51–61.</span> [<a href="/pubmed/20389085" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20389085</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.von_gernet.2000.137">von Gernet S, Golla A, Ehrenfels Y, Schuffenhauer S, Fairley JD. Genotype-phenotype analysis in Apert syndrome suggests opposite effects of the two recurrent mutations on syndactyly and outcome of craniofacial surgery. <span><span class="ref-journal">Clin Genet. </span>2000;<span class="ref-vol">57</span>:137–9.</span> [<a href="/pubmed/10735635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10735635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.warman.1993.444">Warman ML, Mulliken JB, Hayward PG, Muller U. Newly recognized autosomal dominant disorder with craniosynostosis. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">46</span>:444–9.</span> [<a href="/pubmed/8357019" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8357019</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.weber.2010.51">Weber B, Schwabegger AH, Vodopiutz J, Janecke AR, Forstner R, Steiner H. Prenatal diagnosis of apert syndrome with cloverleaf skull deformity using ultrasound, fetal magnetic resonance imaging and genetic analysis. <span><span class="ref-journal">Fetal Diagn Ther. </span>2010;<span class="ref-vol">27</span>:51–6.</span> [<a href="/pubmed/19940464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19940464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.white.2005.361">White KE, Cabral JM, Davis SI, Fishburn T, Evans WE, Ichikawa S, Fields J, Yu X, Shaw NJ, McLellan NJ, McKeown C, Fitzpatrick D, Yu K, Ornitz DM, Econs MJ. Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">76</span>:361–7.</span> [<a href="/pmc/articles/PMC1196382/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1196382</span></a>] [<a href="/pubmed/15625620" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15625620</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.wilkie.2005.187">Wilkie AO. Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. <span><span class="ref-journal">Cytokine Growth Factor Rev. </span>2005;<span class="ref-vol">16</span>:187–203.</span> [<a href="/pubmed/15863034" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15863034</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.wilkie.1997.1647">Wilkie AO. Craniosynostosis: genes and mechanisms. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:1647–56.</span> [<a href="/pubmed/9300656" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9300656</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.wilkie.2010.e391">Wilkie AO, Byren JC, Hurst JA, Jayamohan J, Johnson D, Knight SJ, Lester T, Richards PG, Twigg SR, Wall SA. Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis. <span><span class="ref-journal">Pediatrics. </span>2010;<span class="ref-vol">126</span>:e391–400.</span> [<a href="/pmc/articles/PMC3535761/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3535761</span></a>] [<a href="/pubmed/20643727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20643727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.wilkie.2001.122">Wilkie AO, Oldridge M, Tang Z, Maxson RE Jr. Craniosynostosis and related limb anomalies. <span><span class="ref-journal">Novartis Found Symp. </span>2001;<span class="ref-vol">232</span>:122–33.</span> [<a href="/pubmed/11277076" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11277076</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.williamson.2006.1797">Williamson L, Arlt W, Shackleton C, Kelley RI, Braddock SR. Linking Antley-Bixler syndrome and congenital adrenal hyperplasia: a novel case of P450 oxidoreductase deficiency. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140A</span>:1797–803.</span> [<a href="/pubmed/16906539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16906539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.wong.2000.2314">Wong GB, Kakulis EG, Mulliken JB. Analysis of fronto-orbital advancement for Apert, Crouzon, Pfeiffer, and Saethre-Chotzen syndromes. <span><span class="ref-journal">Plast Reconstr Surg. </span>2000;<span class="ref-vol">105</span>:2314–23.</span> [<a href="/pubmed/10845283" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10845283</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.yin.2008.631">Yin L, Du X, Li C, Xu X, Chen Z, Su N, Zhao L, Qi H, Li F, Xue J, Yang J, Jin M, Deng C, Chen L. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis. <span><span class="ref-journal">Bone. </span>2008;<span class="ref-vol">42</span>:631–43.</span> [<a href="/pubmed/18242159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18242159</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.yoon.2009.e1000558">Yoon SR, Qin J, Glaser RL, Jabs EW, Wexler NS, Sokol R, Arnheim N, Calabrese P. The ups and downs of mutation frequencies during aging can account for the Apert syndrome paternal age effect. <span><span class="ref-journal">PLoS Genet. </span>2009;<span class="ref-vol">5</span>:e1000558.</span> [<a href="/pmc/articles/PMC2700275/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2700275</span></a>] [<a href="/pubmed/19593369" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19593369</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.zackai.2003.209">Zackai EH, McDonald-McGinn DM, Stolle C, Huff DS. Craniosynostosis with tracheal sleeve: a patient with Pfeiffer syndrome, tracheal sleeve and additional malformations in whom an FGFR2 mutation was found. <span><span class="ref-journal">Clin Dysmorphol. </span>2003;<span class="ref-vol">12</span>:209.</span> [<a href="/pubmed/14564165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14564165</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="craniosynostosis.REF.zarate.2010.638">Zarate YA, Putnam PE, Saal HM. Intestinal malrotation in a patient with Pfeiffer syndrome type 2. <span><span class="ref-journal">Cleft Palate Craniofac J. </span>2010;<span class="ref-vol">47</span>:638–41.</span> [<a href="/pubmed/20509766" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20509766</span></a>]</div></li></ul></div></div><div id="craniosynostosis.Chapter_Notes"><h2 id="_craniosynostosis_Chapter_Notes_">Chapter Notes</h2><div id="craniosynostosis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 June 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 September 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 January 2006 (nr) Revision: <a class="figpopup" href="/books/NBK1455/table/craniosynostosis.T.molecular_genetic_tes/?report=objectonly" target="object" rid-figpopup="figcraniosynostosisTmoleculargenetictes" rid-ob="figobcraniosynostosisTmoleculargenetictes">Table 3</a>, Pfeiffer syndrome</div></li><li class="half_rhythm"><div>18 April 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>13 February 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 October 1998 (pb) Review posted live</div></li><li class="half_rhythm"><div>March 1998 (nr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1455</span><span class="label">PMID: <a href="/pubmed/20301628" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301628</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fbxl4-mtddepl/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fkbp14-keds/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1455&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1455/?report=reader">PubReader</a></li><li><a href="/books/NBK1455/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1455" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1455" style="display:none" title="Cite this Page"><div class="bk_tt">Robin NH, Falk MJ, Haldeman-Englert CR. FGFR-Related Craniosynostosis Syndromes. 1998 Oct 20 [Updated 2011 Jun 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1455/pdf/Bookshelf_NBK1455.pdf">PDF version of this page</a> (599K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#craniosynostosis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#craniosynostosis.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#craniosynostosis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#craniosynostosis.Clinical_Characteristic" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#craniosynostosis.Genetically_Related_All" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#craniosynostosis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#craniosynostosis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#craniosynostosis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#craniosynostosis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#craniosynostosis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#craniosynostosis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#craniosynostosis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2261[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FGFR3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2263[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FGFR2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2260[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FGFR1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1498004" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1498004" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1498004" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1498004" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301588" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Muenke Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Muenke Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kruszka P, Addissie YA, Agochukwu NB, Doherty ES, Muenke M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31145570" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wenger TL, Hing AV, Evans KN. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27226847" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Genetic Syndromes Associated with Craniosynostosis.</a><span class="source">[J Korean Neurosurg Soc. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Genetic Syndromes Associated with Craniosynostosis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ko JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Korean Neurosurg Soc. 2016 May; 59(3):187-91. Epub 2016 May 10.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25441602" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hearing loss in syndromic craniosynostoses: otologic manifestations and clinical findings.</a><span class="source">[Int J Pediatr Otorhinolaryngol...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hearing loss in syndromic craniosynostoses: otologic manifestations and clinical findings.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Agochukwu NB, Solomon BD, Muenke M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Int J Pediatr Otorhinolaryngol. 2014 Dec; 78(12):2037-47. Epub 2014 Sep 28.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/7493034" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.</a><span class="source">[Nat Genet. 1995]</span><div class="brieflinkpop offscreen_noflow">Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Nat Genet. 1995 Dec; 11(4):462-4. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301628" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301628" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0413a539a66ee2bacd71c3">FGFR-Related Craniosynostosis Syndromes - GeneReviews®</a><div class="ralinkpop offscreen_noflow">FGFR-Related Craniosynostosis Syndromes - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:57:57-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CDD20E0410B3100000000013A0078&amp;ncbi_session=CE8CDD20E0413A41_0314SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1455%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1455&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1455/&amp;ncbi_pagename=FGFR-Related Craniosynostosis Syndromes - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CDD20E0413A41_0314SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>